Coxibs

RX_COXIBS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — M01AH 1 out of 7 registries used, show all original rules.	121102
4. Check minimum number of events Min. number of events 3	121102
5. Include endpoints None	121102
6. Filter based on genotype QC (FinnGen only)	121102

Control definitions (FinnGen only)

Control exclude: RX_NSAID

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_COXIBS
CONTROL_EXCLUDE	RX_NSAID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	M01AH
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Coxibs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	121102	75520	45582
Unadjusted period prevalence (%)	23.62	25.74	20.09
Median age at first event (years)	50.94	50.28	52.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1884: Matched controls
15361

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M01AB05

ATC

diclofenac; systemic, rectal

14.4

323.0

991

1096

M03BX02

ATC

tizanidine; oral

12.7

323.0

863

956

M01AH01

ATC

celecoxib; oral (coxibs)

55.8

323.0

471

N02BE01

ATC

paracetamol; systemic, rectal

8.4

323.0

1440

4270

M01AH05

ATC

etoricoxib; oral

118.1

323.0

1526

534

N02AX02

ATC

tramadol; systemic, rectal

9.3

296.0

738

995

M01AE01

ATC

ibuprofen; systemic, rectal

6.9

296.0

1465

5183

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

9.6

261.9

623

750

M01AH02

ATC

rofecoxib; oral

41.2

252.9

338

M01AC06

ATC

meloxicam; systemic, rectal

19.1

249.8

416

224

M01AE02

ATC

naproxen; oral, rectal

5.6

241.3

1007

2622

N02AJ06

ATC

codeine and paracetamol; systemic

8.9

239.1

596

762

A02BC02

ATC

pantoprazole; systemic

5.6

232.0

924

2248

M54.5

ICD-10 Finland

Low back pain

8.4

231.5

598

805

N03AX16

ATC

pregabalin; oral

15.2

189.4

343

221

M25.5

ICD-10 Finland

Pain in joint

7.7

171.5

459

620

M79.6

ICD-10 Finland

Pain in limb

6.0

170.8

561

1006

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

16.2

165.5

291

171

M03BC01

ATC

orphenadrine (citrate); systemic

13.7

164.7

312

220

J01DB01

ATC

cefalexin; oral

4.0

160.4

1348

5973

A07EC01

ATC

sulfasalazine; oral, rectal

27.5

159.7

235

N03AX12

ATC

gabapentin; oral

21.5

148.4

235

101

M01AE03

ATC

ketoprofen; systemic, rectal

6.0

140.1

451

766

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

32.3

138.9

196

A02BC05

ATC

esomeprazole; systemic

5.3

131.8

476

921

M03BC51

ATC

orphenadrine, combinations; systemic

8.5

131.5

321

363

M54.4

ICD-10 Finland

Lumbago with sciatica

16.0

129.2

227

130

M01AX17

ATC

nimesulide; oral

12.2

127.1

252

192

H02AB06

ATC

prednisolone; systemic

3.7

126.4

752

2343

M01AX05

ATC

glucosamine; oral

44.2

124.5

164

J01AA02

ATC

doxycycline; systemic

3.2

121.5

998

3953

M02AA07

ATC

piroxicam; topical

5.3

119.3

427

808

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

24.8

113.8

172

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.5

106.7

666

2092

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

16.4

105.5

183

100

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

102.5

101.0

118

L03

ICPC

Low back symptom/complaint

4.6

100.9

414

892

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

124.7

100.3

115

M75.1

ICD-10 Finland

Rotator cuff syndrome

13.7

94.3

176

115

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

17.1

89.9

153

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

29.9

88.6

127

M54.9

ICD-10 Finland

Dorsalgia, unspecified

7.9

88.5

222

255

N06AX11

ATC

mirtazapine; oral

3.8

88.1

452

1183

M02AA10

ATC

ketoprofen; topical

8.8

86.0

201

205

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

84.8

470

1307

X59

ICD-10 Finland

Exposure to unspecified factor

4.6

80.8

324

669

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

100.7

80.3

R4110

NOMESCO Finland

Physiotherapy

4.2

75.6

329

733

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

75.5

525

1708

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

6.3

74.2

217

309

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.7

72.9

369

939

M45

ICD-10 Finland

Ankylosing spondylitis

103.6

72.9

M17.1

ICD-10 Finland

Other primary gonarthrosis

15.4

70.2

124

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

79.6

69.9

M54

ICD-10 Finland

Dorsalgia

6.8

69.3

191

250

R01AD09

ATC

mometasone; nasal

2.8

68.4

579

2118

A02BC03

ATC

lansoprazole; oral

3.7

68.0

346

880

A02BC01

ATC

omeprazole; systemic

3.3

68.0

420

1242

G04CA02

ATC

tamsulosin; oral

3.1

67.4

449

1400

R03AC02

ATC

salbutamol; inhalant

2.5

67.4

795

3507

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.5

67.4

192

263

R01AD12

ATC

fluticasone furoate; nasal

3.2

67.3

432

1313

P01BA02

ATC

hydroxychloroquine; oral

19.0

66.2

108

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.4

66.2

859

3970

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

65.5

325

807

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.4

64.4

820

3737

M13.9

ICD-10 Finland

Arthritis, unspecified

11.4

64.2

129

A06AC01

ATC

ispaghula (psylla seeds); oral

4.0

64.2

292

671

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.7

64.0

329

841

J01CE02

ATC

phenoxymethylpenicillin; oral

2.3

63.6

1151

6222

X58

ICD-10 Finland

Exposure to other specified factors

4.3

61.0

255

540

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

59.4

339

937

R53

ICD-10 Finland

Malaise and fatigue

3.1

58.7

387

1186

J01MA02

ATC

ciprofloxacin; systemic

2.7

58.4

494

1779

J01FF01

ATC

clindamycin; systemic

3.4

58.0

320

860

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.1

57.1

376

1150

M09AX01

ATC

hyaluronic acid; parenteral

23.2

56.9

N05CF01

ATC

zopiclone; oral

2.8

56.9

450

1551

R07.4

ICD-10 Finland

Chest pain, unspecified

3.7

56.1

280

693

S18

ICPC

Laceration/cut

2.7

54.5

456

1621

M79.1

ICD-10 Finland

Myalgia

5.2

54.5

187

321

R10.1

ICD-10 Finland

Pain localized to upper abdomen

4.3

54.2

222

459

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

53.7

323

922

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.4

53.7

302

820

WX408

NOMESCO Finland

General anesthesy, balanced

3.4

53.2

299

809

P01AB01

ATC

metronidazole; oral, rectal

2.9

53.2

397

1313

R03AK07

ATC

formoterol and budesonide; inhalant

4.0

52.9

239

541

R42

ICD-10 Finland

Dizziness and giddiness

3.5

52.2

283

746

N06AX21

ATC

duloxetine; oral

7.2

52.2

137

166

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.9

51.9

363

1150

R51.80

ICD-10 Finland

Headache

3.7

51.7

252

609

M48.0

ICD-10 Finland

Spinal stenosis

11.5

51.6

103

G44.2

ICD-10 Finland

Tension-type headache

5.2

51.2

173

291

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

13.6

51.0

M01AG02

ATC

tolfenamic acid; oral, rectal

13.7

50.6

WX110

NOMESCO Finland

Local anesthesy

2.1

50.2

1026

5586

C07AB07

ATC

bisoprolol; oral

2.5

50.0

476

1809

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

49.9

422

1499

L28

ICPC

Limited function/disability (L)

4.5

49.2

191

373

M53.1

ICD-10 Finland

Cervicobrachial syndrome

8.1

48.5

117

124

J02AC01

ATC

fluconazole; systemic

2.9

48.4

343

1090

ZXA00

NOMESCO Finland

Right side

3.2

47.7

289

825

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.7

47.7

399

1404

M01AH03

ATC

valdecoxib; oral

38.5

47.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.2

47.0

622

2775

L04AB01

ATC

etanercept; parenteral

148.1

46.9

N02AA05

ATC

oxycodone; systemic

4.8

46.9

172

316

N05BA04

ATC

oxazepam; oral

2.8

46.7

366

1236

M01AB01

ATC

indometacin; systemic, rectal

7.9

46.5

114

124

M16.1

ICD-10 Finland

Other primary coxarthrosis

11.5

46.4

L88

ICPC

Rheumatoid/seropositive arthritis

30.5

45.9

R03DC03

ATC

montelukast; oral

3.7

45.9

223

535

C09CA06

ATC

candesartan; oral

5.4

45.3

148

239

G43.9

ICD-10 Finland

Migraine, unspecified

7.3

43.8

113

133

R06.0

ICD-10 Finland

Dyspnoea

2.9

43.5

313

999

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

43.5

637

2954

R06AE07

ATC

cetirizine; oral

2.1

43.3

664

3138

N05CF02

ATC

zolpidem; oral

4.8

43.3

156

281

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.2

43.2

179

372

G04CA01

ATC

alfuzosin; oral

4.4

42.8

171

343

J01CA04

ATC

amoxicillin; systemic

2.1

42.6

1446

9356

L15

ICPC

Knee symptom/complaint

3.1

42.5

271

796

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

42.1

220

559

G56.0

ICD-10 Finland

Carpal tunnel syndrome

9.1

42.0

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

20.6

41.9

L08

ICPC

Shoulder symptom/complaint

4.6

41.6

156

293

WX002

NOMESCO Finland

Sedation and analgesia

4.1

41.3

179

387

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

8.7

41.3

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

22.1

40.9

J01DA01

ATC

[U] cefalexin; systemic

1.9

40.6

967

5405

A01

ICPC

Pain general/multiple sites

5.5

40.2

128

200

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

17.1

40.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

39.9

991

5612

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.7

39.6

189

445

R01AD08

ATC

fluticasone; nasal

2.6

39.6

340

1203

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

66.9

39.3

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.5

39.2

126

199

M04AA01

ATC

allopurinol; systemic

3.6

39.2

193

466

B01AB05

ATC

enoxaparin; parenteral

3.7

38.9

191

460

ZXA05

NOMESCO Finland

Left side

2.9

38.4

262

805

D07AC01

ATC

betamethasone; topical

2.4

38.3

403

1585

XKD00

NOMESCO Finland

Uroflowmetry

3.4

37.8

206

538

H25.1

ICD-10 Finland

Senile nuclear cataract

2.5

37.8

334

1198

N05AH04

ATC

quetiapine; oral

2.5

37.6

333

1194

R06AX27

ATC

desloratadine; oral

2.4

37.6

388

1508

S93.4

ICD-10 Finland

Sprain and strain of ankle

3.0

37.1

244

730

M53.0

ICD-10 Finland

Cervicocranial syndrome

7.1

36.2

112

EMB10

NOMESCO Finland

Tonsillectomy

4.3

36.2

144

287

M01AB55

ATC

diclofenac, combinations; oral

10.6

36.0

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

5.2

35.7

120

200

M70.6

ICD-10 Finland

Trochanteric bursitis

19.1

35.5

SPAT1153

SPAT

Removal of sutures

2.7

35.4

270

886

WX320

NOMESCO Finland

Spinalanesthesy

3.8

35.3

164

377

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

5.7

35.1

108

162

J35.0

ICD-10 Finland

Chronic tonsillitis

5.1

35.0

119

201

L13

ICPC

Hip symptom/complaint

4.9

35.0

122

212

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

34.9

622

3064

J01MA12

ATC

levofloxacin; systemic

3.0

34.9

223

653

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.3

34.7

405

1664

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.0

34.5

111

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

5.9

34.5

103

149

L16

ICPC

Ankle symptom/complaint

3.2

34.3

205

571

M01AC01

ATC

piroxicam; systemic, rectal

7.7

34.0

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

2.8

33.9

243

766

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

7.7

33.8

M54.2

ICD-10 Finland

Cervicalgia

8.5

33.6

N40

ICD-10 Finland

Hyperplasia of prostate

2.5

33.4

315

1163

AA1AD

NOMESCO Finland

CT of head and brain

3.1

33.4

206

588

F51.0

ICD-10 Finland

Nonorganic insomnia

3.2

33.4

191

517

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

19.3

33.1

M54.6

ICD-10 Finland

Pain in thoracic spine

6.0

33.1

137

C07AA05

ATC

propranolol; systemic

2.7

33.1

254

835

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.6

32.9

122

226

L02

ICPC

Back symptom/complaint

3.5

32.9

167

413

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.2

32.7

404

1702

M01AE11

ATC

tiaprofenic acid; oral, rectal

18.5

32.7

N06AX16

ATC

venlafaxine; oral

3.2

32.4

192

533

J01FA10

ATC

azithromycin; systemic

1.8

32.4

966

5659

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

26.2

32.2

R51

ICD-10 Finland

Headache

5.1

31.8

108

182

J01FA09

ATC

clarithromycin; systemic

2.3

31.7

360

1456

L04AB04

ATC

adalimumab; parenteral

14.1

31.7

D07AB02

ATC

hydrocortisone butyrate; topical

2.2

31.6

385

1608

D07AC13

ATC

mometasone; topical

2.3

31.4

339

1337

E0000UV

ATC

1.9

31.4

600

3007

G43

ICD-10 Finland

Migraine

6.6

31.4

111

L12

ICPC

Hand/finger symptom/complaint

2.7

31.0

234

761

NF1AA

NOMESCO Finland

Hip X-ray examination

6.8

30.9

104

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

8.9

30.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

5.4

30.8

157

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

12.6

30.3

L17

ICPC

Foot/toe symptom/complaint

2.4

30.0

305

1165

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

21.3

29.7

W19

ICD-10 Finland

Unspecified fall

3.2

29.7

168

450

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

29.7

232

768

M10.9

ICD-10 Finland

Gout, unspecified

7.5

29.7

C10AA01

ATC

simvastatin; oral

2.3

29.6

301

1150

S06.0

ICD-10 Finland

Concussion

2.9

29.5

196

585

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

29.2

251

875

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

29.0

258

917

L86

ICPC

Back syndrome with radiating pain

11.1

29.0

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

36.0

28.9

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

23.9

28.8

M01AB08

ATC

etodolac; oral

17.8

28.7

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.1

28.4

120

253

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

49.8

28.3

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

10.1

28.2

J01FA06

ATC

roxithromycin; oral

2.0

28.0

425

1935

ZXA10

NOMESCO Finland

Bilateral

2.8

27.9

199

623

J05AB01

ATC

aciclovir; systemic

2.7

27.7

214

702

UKC02

NOMESCO Finland

Cystoscopy

2.6

27.6

217

721

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

12.4

27.5

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

27.5

238

832

M54.8

ICD-10 Finland

Other dorsalgia

9.5

27.4

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

27.2

225

768

L01

ICPC

Neck symptom/complaint

3.1

27.1

166

468

A28

ICPC

Limited function/disability NOS

3.2

27.1

152

405

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.8

27.1

124

281

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

4.6

26.9

100

186

R74

ICPC

Upper respiratory infection acute

1.9

26.9

531

2664

C08CA01

ATC

amlodipine; oral

2.6

26.7

223

766

M77.1

ICD-10 Finland

Lateral epicondylitis

11.1

26.6

A06AD11

ATC

lactulose; oral

2.2

26.6

295

1171

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

30.8

26.5

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

26.3

26.2

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

11.9

26.1

KMAK

NOMESCO Finland

1.8

26.0

597

3144

WX290

NOMESCO Finland

Other blockade of nerve

1.7

25.9

714

3983

S83.2

ICD-10 Finland

Tear of meniscus, current

6.4

25.9

N06AB10

ATC

escitalopram; oral

2.2

25.9

315

1304

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.7

25.7

165

K30

ICD-10 Finland

Functional dyspepsia

4.1

25.7

107

223

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

25.5

171

514

N04BC05

ATC

pramipexole; oral

7.4

25.5

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

82.8

25.3

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.1

25.2

147

402

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

18.0

25.2

R52.2

ICD-10 Finland

Other chronic pain

10.7

25.2

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

4.3

25.1

196

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

25.1

148

409

N01

ICPC

Headache

2.1

24.9

325

1384

M77.4

ICD-10 Finland

Metatarsalgia

6.5

24.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.6

24.6

115

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

24.6

162

482

S80.0

ICD-10 Finland

Contusion of knee

3.7

24.6

116

270

D11

ICPC

Diarrhoea

2.5

24.5

209

724

SPAT1216

SPAT

Assessment of functional ability

3.1

24.4

143

393

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

8.7

24.3

R52.9

ICD-10 Finland

Pain, unspecified

4.0

23.8

101

214

UJF32

NOMESCO Finland

Coloscopy

2.5

23.8

213

757

D07XC01

ATC

betamethasone, combinations; topical

3.0

23.7

146

415

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

23.7

193

652

M79.7

ICD-10 Finland

Fibromyalgia

14.8

23.5

N89

ICPC

Migraine

4.7

23.5

154

A02BA02

ATC

ranitidine; systemic

2.4

23.5

228

844

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

23.4

170

537

EBA10

NOMESCO Finland

Surgical removal of tooth

2.1

23.4

324

1411

C03CA01

ATC

furosemide; systemic

1.8

23.4

461

2293

OAA65

SPAT

2.9

23.4

154

456

M19.0

ICD-10 Finland

Primary arthrosis of other joints

19.2

23.3

L04AB06

ATC

golimumab; parenteral

36.7

23.1

C05AA08

ATC

fluocortolone; rectal, topical

3.8

22.7

103

232

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

11.4

22.6

L04AA13

ATC

leflunomide; oral

74.4

22.6

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

74.4

22.6

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

10.4

22.5

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

10.4

22.5

SPAT1283

SPAT

Restricted health certificate

1.8

22.5

453

2265

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

22.4

422

2060

R50.9

ICD-10 Finland

Fever, unspecified

2.3

22.4

229

870

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

13.1

22.4

SPAT1263

SPAT

Sampling

1.7

22.4

600

3285

W00

ICD-10 Finland

Fall on same level involving ice and snow

3.0

22.2

141

409

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

22.2

185

633

R60.0

ICD-10 Finland

Localized oedema

4.2

22.2

183

SPAT1260

SPAT

Consultation of another employee

2.3

22.2

232

891

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.6

22.1

149

M23.8

ICD-10 Finland

Other internal derangements of knee

10.4

22.1

M54.3

ICD-10 Finland

Sciatica

13.3

22.0

SPAT1301

SPAT

No procedures

1.8

22.0

437

2172

H02AB07

ATC

prednisone; oral

2.5

21.9

188

652

L11

ICPC

Wrist symptom/complaint

2.9

21.9

143

423

E66.01

ICD-10 Finland

Obesity due to excess calories

4.3

21.8

163

K10.3

ICD-10 Finland

Alveolitis of jaws

5.5

21.7

102

SPAT1254

SPAT

Administration of medicine

2.0

21.7

313

1383

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.5

21.6

183

629

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

21.6

656

3713

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.9

21.5

359

1677

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

21.2

531

2838

R11

ICD-10 Finland

Nausea and vomiting

2.9

21.2

138

407

D01

ICPC

Abdominal pain/cramps general

2.3

21.2

211

791

R02

ICPC

Shortness of breath/dyspnoea

2.8

21.1

147

453

N05BA12

ATC

alprazolam; oral

3.8

21.0

209

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

44.6

21.0

SPAT1211

SPAT

Application of soft bandage

2.7

21.0

155

494

OAB43

SPAT

2.1

21.0

272

1150

W22

ICD-10 Finland

Striking against or struck by other object(s)

3.1

20.9

123

339

NA3BG

SPAT

16.1

20.8

J45

ICD-10 Finland

Asthma

3.3

20.8

112

290

H02BX01

ATC

methylprednisolone, combinations; systemic

7.2

20.7

M76.6

ICD-10 Finland

Achilles tendinitis

9.9

20.7

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

8.7

20.5

J20

ICD-10 Finland

Acute bronchitis

3.8

20.5

201

N03AE01

ATC

clonazepam; systemic

5.3

20.5

102

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.6

20.3

132

M01AX01

ATC

nabumetone; oral

21.4

20.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.3

20.3

155

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.6

20.3

136

R05

ICPC

Cough

2.0

20.3

281

1221

R03BA05

ATC

fluticasone; inhalant

2.0

20.3

281

1221

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

20.2

193

708

S83.5

ICD-10 Finland

Sprain and strain involving (anterior)(posterior) cruciate ligament of knee

5.5

20.2

N02CC05

ATC

almotriptan; oral

18.9

20.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

20.1

667

3851

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

20.0

211

812

WZA10

NOMESCO Finland

Long statement of health and health related matters

15.7

20.0

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

5.6

19.9

Z71.8

ICD-10 Finland

Other specified counselling

1.9

19.9

338

1583

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.3

19.8

108

282

N02CC07

ATC

frovatriptan; oral

11.7

19.8

R06AX22

ATC

ebastine; oral

2.7

19.7

142

446

A02BC04

ATC

rabeprazole; oral

5.6

19.7

R05FB02

ATC

cough suppressants and expectorants

1.8

19.7

376

1837

C10AA05

ATC

atorvastatin; oral

2.6

19.6

159

534

R07.3

ICD-10 Finland

Other chest pain

3.6

19.6

214

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

19.5

221

881

R05

ICD-10 Finland

Cough

2.3

19.3

199

756

J02AC02

ATC

itraconazole; systemic

3.0

19.3

119

338

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

8.7

19.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.9

19.3

179

D07AD01

ATC

clobetasol; topical

3.0

19.3

120

344

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

4.1

19.3

163

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

4.6

19.2

129

G04BD07

ATC

tolterodine; oral

4.1

19.1

164

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

19.1

126

373

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

19.1

173

617

SPAT1310

SPAT

Counselling related to known health issue

1.7

19.0

479

2549

N06AA09

ATC

amitriptyline; systemic

4.7

19.0

119

A46

ICD-10 Finland

Erysipelas

2.8

19.0

127

382

NE1AA

NOMESCO Finland

Pelvis X-ray examination

5.2

18.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

5.9

18.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

18.9

114

320

A03

ICPC

Fever

1.9

18.9

317

1478

SPAT1229

SPAT

Assessment of need for aid

4.3

18.8

139

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.4

18.8

171

611

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

18.8

376

1860

JAH01

NOMESCO Finland

Laparoscopy

8.5

18.6

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

12.1

18.6

ACC51

NOMESCO Finland

Release of median nerve

12.8

18.5

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

10.6

18.5

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

18.4

294

1344

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

18.4

303

1402

N05BA01

ATC

diazepam; systemic, rectal

2.4

18.4

163

574

C09AA05

ATC

ramipril; oral

2.3

18.4

191

730

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

11.1

18.3

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

21.0

18.3

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

39.6

18.3

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

39.6

18.3

N02CC04

ATC

rizatriptan; oral

9.9

18.3

J01EA01

ATC

trimethoprim; systemic

1.9

18.2

319

1509

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

13.9

18.1

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

2.8

18.0

125

384

N30.0

ICD-10 Finland

Acute cystitis

2.2

17.9

192

745

WZA00

NOMESCO Finland

Short statement of of health and health related matters

3.3

17.8

240

SPAT1104

SPAT

Monitoring of emergency patient

3.8

17.6

169

M05BA04

ATC

alendronic acid; oral

4.8

17.6

107

R52.0

ICD-10 Finland

Acute pain

6.5

17.5

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

8.3

17.5

J01CA08

ATC

pivmecillinam; oral

1.7

17.5

391

2000

G04BD08

ATC

solifenacin; oral

5.2

17.4

N94.4

ICD-10 Finland

Primary dysmenorrhoea

4.1

17.4

146

J01

ICD-10 Finland

Acute sinusitis

4.5

17.4

119

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

37.9

17.4

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

17.4

253

1114

D01BA02

ATC

terbinafine; oral; topical

2.3

17.3

167

615

E000001

ATC

1.8

17.3

330

1604

G04CB02

ATC

dutasteride; oral

3.8

17.2

164

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.5

17.1

114

R06AE09

ATC

levocetirizine; oral

2.2

17.1

186

724

S89.9

ICD-10 Finland

Unspecified injury of lower leg

5.2

17.0

M75.8

ICD-10 Finland

Other shoulder lesions

7.9

17.0

A04AA01

ATC

ondansetron; systemic, rectal

4.9

16.9

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.4

16.8

1499

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

16.8

208

857

K07.60

ICD-10 Finland

Snapping jaw

4.0

16.8

143

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

22.9

16.8

K02.1

ICD-10 Finland

Caries of dentine

1.5

16.7

807

5044

A06AC51

ATC

ispaghula, combinations; systemic

6.3

16.7

L09

ICPC

Arm symptom/complaint

4.2

16.7

132

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

4.1

16.7

136

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

16.6

165

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

16.6

141

486

N02CC03

ATC

zolmitriptan; nasal, oral

9.0

16.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

16.6

236

1031

L40.5

ICD-10 Finland

Arthropathic psoriasis

36.2

16.5

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.5

16.5

140

482

D06

ICPC

Abdominal pain localized other

2.7

16.5

118

368

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

16.5

434

2324

L29

ICPC

Musculoskeletal sympt/complt other

3.5

16.5

192

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

16.4

195

793

EBA00

NOMESCO Finland

Extraction of tooth

1.6

16.4

487

2699

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

16.3

160

F51

ICD-10 Finland

Nonorganic sleep disorders

4.8

16.2

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

16.2

503

2819

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

54.8

16.2

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

14.5

16.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

14.5

16.1

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

14.5

16.1

G04BD12

ATC

mirabegron; oral

6.1

16.1

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

2.1

16.1

197

809

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

148.1

16.1

M10.0

ICD-10 Finland

Idiopathic gout

10.6

16.1

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

16.1

285

1348

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.9

16.0

275

1287

J01DC02

ATC

cefuroxime; systemic

4.1

16.0

130

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

22.0

16.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

4.5

16.0

107

L14

ICPC

Leg/thigh symptom/complaint

3.2

15.9

236

H02AB04

ATC

methylprednisolone; systemic

2.4

15.9

146

525

A29

ICPC

General symptom/complaint other

2.5

15.9

131

445

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.9

15.9

258

1185

R01BA52

ATC

pseudoephedrine, combinations; oral

2.9

15.8

103

303

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.2

15.8

166

636

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.2

15.7

175

690

R00.2

ICD-10 Finland

Palpitations

3.3

15.7

213

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

6.5

15.7

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

5.6

15.7

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

8.5

15.7

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.8

15.6

153

R33

ICD-10 Finland

Retention of urine

2.4

15.6

143

513

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

3.1

15.6

236

N06AB04

ATC

citalopram; systemic

2.0

15.6

215

925

GD1AA

SPAT

3.6

15.6

166

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.6

15.6

123

408

G47.3

ICD-10 Finland

Sleep apnoea

3.0

15.5

260

A99

ICPC

Disease/condition unspecnature/site

3.0

15.5

260

DHB50

NOMESCO Finland

Turbinoplasty

8.3

15.4

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

8.3

15.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

15.4

133

462

R35

ICD-10 Finland

Polyuria

4.0

15.4

131

WX402

NOMESCO Finland

General anaesthesia

2.5

15.3

130

447

N06AB06

ATC

sertraline; oral

2.2

15.3

159

607

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

7.9

15.3

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

15.3

143

517

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

15.3

264

ZX120

NOMESCO Finland

Intravenous

2.7

15.2

108

337

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

74.1

15.2

L84

ICPC

Back syndrome without radiat pain

4.9

15.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

15.1

728

4514

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

15.1

104

319

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.7

15.1

158

N02CC06

ATC

eletriptan; oral

9.9

15.1

SGA01

NOMESCO Finland

Tooth opening as first aid

2.1

15.0

172

687

G43.3

ICD-10 Finland

Complicated migraine

14.3

15.0

R01AD01

ATC

beclometasone; nasal

2.5

15.0

120

402

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

15.0

104

321

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.3

14.9

141

513

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

10.3

14.9

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.4

14.9

190

S01GX01

ATC

cromoglicic acid; ophthalmic

1.9

14.9

243

1116

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

7.1

14.8

S69.9

ICD-10 Finland

Unspecified injury of wrist and hand

6.6

14.8

R03BB04

ATC

tiotropium bromide; inhalant

2.4

14.8

132

467

W10

ICD-10 Finland

Fall on and from stairs and steps

3.9

14.8

132

NGE35

NOMESCO Finland

Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic

5.8

14.8

B01AC04

ATC

clopidogrel; oral

2.7

14.6

104

324

L20

ICPC

Joint symptom/complaint NOS

5.2

14.6

K05.22

ICD-10 Finland

Acute pericoronitis

2.0

14.6

192

813

M10

ICD-10 Finland

Gout

9.2

14.5

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

9.2

14.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

14.4

225

1015

R55

ICD-10 Finland

Syncope and collapse

2.2

14.4

153

591

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

3.8

14.4

135

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

49.3

14.4

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

49.3

14.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.0

14.3

R4120

NOMESCO Finland

Occupational therapy

3.7

14.3

144

S22.3

ICD-10 Finland

Fracture of rib

4.0

14.3

124

M35.7

ICD-10 Finland

Hypermobility syndrome

10.0

14.2

A98

ICPC

Health maint/preventive medicine

1.5

14.2

1328

9426

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

13.8

14.2

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

14.2

144

545

K59.0

ICD-10 Finland

Constipation

2.7

14.1

102

322

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.0

14.1

239

SPAT1097

SPAT

Recording of ECG

2.9

14.1

257

B02AA02

ATC

tranexamic acid; systemic

2.5

14.0

114

385

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.8

14.0

278

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

7.1

14.0

N06AA10

ATC

nortriptyline; systemic

21.6

14.0

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

21.6

14.0

TLC00

NOMESCO Finland

Insertion of intrauterine device

4.6

13.9

R10.0

ICD-10 Finland

Acute abdomen

4.5

13.9

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

12.9

13.8

Z02.4

ICD-10 Finland

Examination for driving licence

2.4

13.8

119

415

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

14.1

13.8

G54.0

ICD-10 Finland

Brachial plexus disorders

10.1

13.8

M67.4

ICD-10 Finland

Ganglion

4.0

13.8

116

KED22

NOMESCO Finland

Transurethral resection of prostate

2.5

13.7

110

369

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

3.2

13.7

198

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

37.0

13.7

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

37.0

13.7

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

13.6

154

612

JN3AD

NOMESCO Finland

Abdominal CT examination

4.2

13.6

106

G56.2

ICD-10 Finland

Lesion of ulnar nerve

9.6

13.5

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.4

13.5

169

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

5.0

13.5

M75.2

ICD-10 Finland

Bicipital tendinitis

46.6

13.5

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.7

13.4

297

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.6

13.4

312

WZA90

NOMESCO Finland

Other doctors statement

1.7

13.4

323

1677

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

4.1

13.3

108

XF404

NOMESCO Finland

Ambulatory ECG

3.1

13.3

207

R03BA02

ATC

budesonide; inhalant

1.9

13.3

221

1021

K08.80

ICD-10 Finland

Toothache NOS

2.8

13.3

255

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

13.3

176

R31

ICD-10 Finland

Unspecified haematuria

2.3

13.2

128

473

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

13.2

197

874

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

13.2

311

R21

ICPC

Throat symptom/complaint

1.6

13.1

458

2620

G04CA52

ATC

tamsulosin and dutasteride; systemic

3.9

13.1

118

R09

ICPC

Sinus symptom/complaint

2.6

13.0

323

C09CA01

ATC

losartan; oral

2.5

13.0

108

370

H91.1

ICD-10 Finland

Presbycusis

3.1

13.0

201

L04

ICPC

Chest symptom/complaint

3.0

13.0

211

H01

ICPC

Ear pain/earache

2.0

13.0

186

815

SPAT1255

SPAT

Intravenous administration of medicine

4.2

13.0

S43.0

ICD-10 Finland

Dislocation of shoulder joint

4.3

12.9

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

5.3

12.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

12.9

221

K04.08

ICD-10 Finland

Other specified pulpit

2.8

12.8

265

J31.0

ICD-10 Finland

Chronic rhinitis

2.9

12.8

240

M79.0

ICD-10 Finland

Rheumatism, unspecified

22.3

12.8

N80.9

ICD-10 Finland

Endometriosis, unspecified

9.3

12.8

M75

ICD-10 Finland

Shoulder lesions

7.7

12.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

12.8

254

1245

D07CC01

ATC

betamethasone and antibiotics; topical

2.2

12.7

136

526

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

12.7

211

974

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.7

12.7

A03FA02

ATC

cisapride; oral, rectal

2.3

12.6

121

444

M43.1

ICD-10 Finland

Spondylolisthesis

13.9

12.6

SPAT1360

SPAT

Extensive global examination

2.9

12.6

238

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

12.6

159

660

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

12.6

123

455

M22.4

ICD-10 Finland

Chondromalacia patellae

6.0

12.6

M22.0

ICD-10 Finland

Recurrent dislocation of patella

6.5

12.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.4

12.5

113

404

R12

ICD-10 Finland

Heartburn

3.1

12.5

187

S50.0

ICD-10 Finland

Contusion of elbow

4.1

12.5

M47.9

ICD-10 Finland

Spondylosis, unspecified

8.3

12.5

N07CA01

ATC

betahistine; oral

3.6

12.4

136

A04

ICPC

Weakness/tiredness general

1.8

12.4

246

1204

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

61.7

12.4

M01AE52

ATC

naproxen and esomeprazole; oral

61.7

12.4

K04.0

ICD-10 Finland

Pulpitis

2.3

12.4

115

417

J01MA06

ATC

norfloxacin; oral

2.6

12.4

320

T78.4

ICD-10 Finland

Allergy, unspecified

3.0

12.4

199

F43.0

ICD-10 Finland

Acute stress reaction

3.4

12.4

154

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

12.4

242

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

12.4

141

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.1

12.3

149

609

SPAT1210

SPAT

Application of cast or individual aid

4.0

12.3

104

H92.0

ICD-10 Finland

Otalgia

3.1

12.3

190

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

12.3

108

380

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

12.3

126

479

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

16.5

12.3

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

16.5

12.3

M01AG01

ATC

mefenamic acid; oral

16.5

12.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

12.3

144

581

ZA1.0

ICD-10 Finland

Shoulder region

14.4

12.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

12.2

189

848

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

12.2

274

J34.2

ICD-10 Finland

Deviated nasal septum

4.8

12.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.1

12.1

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.3

12.1

115

421

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.5

12.1

101

345

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

12.1

321

L40.0

ICD-10 Finland

Psoriasis vulgaris

4.1

12.1

H26.4

ICD-10 Finland

After-cataract

2.9

12.1

212

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

12.0

271

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.6

12.0

301

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

12.0

346

1882

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

21.1

12.0

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

21.1

12.0

L50.0

ICD-10 Finland

Allergic urticaria

4.6

12.0

AN1

Coronary angiography

2.9

11.9

209

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.7

11.9

116

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.1

11.8

139

562

WZC30

NOMESCO Finland

Teaching

2.9

11.8

205

S70.0

ICD-10 Finland

Contusion of hip

3.6

11.8

125

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.3

11.7

115

427

N07BA03

ATC

varenicline; oral

5.0

11.7

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

11.7

368

2045

SPAT1304

SPAT

Counselling and guidance related to ageing

4.5

11.7

NA3CG

SPAT

23.3

11.7

TNG10

NOMESCO Finland

Puncture of knee

23.3

11.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

11.6

258

1304

R05DA01

ATC

ethylmorphine; oral

2.7

11.6

261

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.6

212

1011

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

9.4

11.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

11.6

214

3007

Kela drug reimbursment

Erenumab and fremanezumab

+∞

11.6

NFF25

NOMESCO Finland

Cleaning of hip joint, arthroscopic

+∞

11.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.3

11.5

N03AX11

ATC

topiramate; oral

7.2

11.5

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

7.2

11.5

J01MA14

ATC

moxifloxacin; systemic

3.0

11.5

186

OAB91

SPAT

6.5

11.5

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

4.1

11.5

M03BX01

ATC

baclofen; systemic

13.7

11.5

M15

ICD-10 Finland

Polyarthrosis

13.7

11.5

K59.1

ICD-10 Finland

Functional diarrhoea

3.2

11.4

164

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.6

11.4

337

1843

H02.3

ICD-10 Finland

Blepharochalasis

7.9

11.4

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

7.0

11.3

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

3.0

11.3

179

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.1

11.3

174

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

3.9

11.2

101

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

11.2

122

N02AC04

ATC

dextropropoxyphene; oral

3.0

11.2

192

J05AB11

ATC

valaciclovir; oral

2.5

11.2

318

R06AX26

ATC

fexofenadine; oral

3.1

11.2

162

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

11.5

11.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

11.5

11.2

SPAT1252

SPAT

Overall medication plan or its review

3.2

11.2

153

D10

ICPC

Vomiting

2.1

11.2

136

556

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.8

11.2

218

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

20.0

11.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.7

11.2

110

R04.0

ICD-10 Finland

Epistaxis

2.6

11.1

267

K07

ICPC

Swollen ankles/oedema

6.0

11.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

11.1

173

779

M25.2

ICD-10 Finland

Flail joint

12.7

11.1

R06AX13

ATC

loratadine; oral

1.8

11.1

196

921

SPAT1053

SPAT

Memory test

2.9

11.1

205

R60.9

ICD-10 Finland

Oedema, unspecified

5.0

11.1

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.6

11.1

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.3

11.1

108

400

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.9

11.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.5

11.0

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.0

10.9

136

562

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.3

10.9

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

10.8

10.9

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.4

10.8

330

C01DA14

ATC

isosorbide mononitrate; oral

1.6

10.8

278

1464

KAY40

NOMESCO Finland

0.4

10.8

890

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.8

10.8

N48.1

ICD-10 Finland

Balanoposthitis

4.1

10.8

A03CA02

ATC

clidinium and psycholeptics; oral

3.4

10.7

131

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

17.5

10.7

D06BB04

ATC

podophyllotoxin; topical

2.9

10.7

196

M77.9

ICD-10 Finland

Enthesopathy, unspecified

5.4

10.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

10.6

168

N02AJ13

ATC

tramadol and paracetamol; systemic

+∞

10.6

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

53.3

10.6

R52.1

ICD-10 Finland

Chronic intractable pain

53.3

10.6

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

10.2

10.6

R03AK08

ATC

formoterol and beclometasone; inhalant

5.8

10.5

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.5

10.5

277

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

4.2

10.5

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

7.9

10.5

M54.1

ICD-10 Finland

Radiculopathy

7.9

10.5

N41.1

ICD-10 Finland

Chronic prostatitis

7.9

10.5

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.8

10.5

XX3DW

NOMESCO Finland

Time consuming IT work

4.1

10.5

B01AA03

ATC

warfarin; systemic

1.6

10.5

276

1463

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

24.6

10.5

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

6.2

10.5

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.6

10.5

L60.0

ICD-10 Finland

Ingrowing nail

2.9

10.5

183

D73

ICPC

Gastroenteritis presumed infection

2.9

10.5

183

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

10.4

228

N06AX22

ATC

agomelatine; oral

4.2

10.4

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

3.7

10.4

100

L57.0

ICD-10 Finland

Actinic keratosis

3.2

10.4

139

P20

ICPC

Memory disturbance

2.8

10.4

209

K05.32

ICD-10 Finland

Periodontitis NOS

1.7

10.4

246

1266

J03

ICD-10 Finland

Acute tonsillitis

2.8

10.3

204

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.4

10.3

122

B01AF02

ATC

apixaban; oral

4.4

10.3

A05

ICPC

Feeling ill

1.7

10.3

206

1009

N05CD07

ATC

temazepam; oral

1.8

10.3

182

855

M47.82

ICD-10 Finland

Other spondylosis, cervical region

15.5

10.3

R96

ICPC

Asthma

2.5

10.3

269

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

9.6

10.3

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

4.2

10.3

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

2.4

10.3

308

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

3.3

10.3

127

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

10.2

163

L81

ICPC

Injury musculoskeletal NOS

4.5

10.2

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

28.7

10.2

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

28.7

10.2

H25.8

ICD-10 Finland

Other senile cataract

2.2

10.2

105

402

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.2

10.2

137

TQW40

NOMESCO Finland

Remowal of suture of skin

3.5

10.1

111

D07AA02

ATC

hydrocortisone; topical

1.6

10.1

254

1328

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

10.1

444

2655

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

10.1

268

M01AC02

ATC

tenoxicam; systemic, rectal

6.5

10.0

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

3.1

10.0

143

N07BB01

ATC

disulfiram; oral

5.0

10.0

K92.0

ICD-10 Finland

Haematemesis

3.4

10.0

121

M13.8

ICD-10 Finland

Other specified arthritis

20.5

10.0

A07AA02

ATC

nystatin; oral

3.3

9.9

126

R07.0

ICD-10 Finland

Pain in throat

2.3

9.9

322

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.1

9.9

152

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

16.4

9.9

EG1CG

NOMESCO Finland

Extensive MRI examination of mandipular joint with high intensity magnet

16.4

9.9

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

9.9

186

894

L04AC10

ATC

secukinumab; parenteral

35.5

9.9

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

35.5

9.9

B01AB04

ATC

dalteparin; parenteral

4.6

9.9

JN4BD

NOMESCO Finland

Extensive body CT

3.2

9.9

131

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

9.9

215

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

9.9

118

ND2AA

SPAT

5.3

9.9

TLC02

NOMESCO Finland

Simple extraction of IUD

6.3

9.8

Z01.2

ICD-10 Finland

Dental examination

1.4

9.8

531

3305

I50.0

ICD-10 Finland

Congestive heart failure

2.0

9.8

138

598

XKD06

NOMESCO Finland

Physiologic investigation of micturition

5.4

9.8

JEA01

NOMESCO Finland

Laparoscopic appendectomy

3.2

9.7

133

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.4

9.7

111

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

49.2

9.7

DJD20

NOMESCO Finland

Plastic repair of septum of nose

7.9

9.7

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

9.7

265

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

23.0

9.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.9

9.6

L18

ICPC

Muscle pain

3.2

9.6

134

OAB48

SPAT

2.0

9.6

131

564

N41.0

ICD-10 Finland

Acute prostatitis

9.1

9.6

WX100

NOMESCO Finland

Conjunctival surface anesthesia

3.7

9.6

D09

ICPC

Nausea

2.0

9.6

122

509

D06BB10

ATC

imiquimod; topical

2.8

9.6

176

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

90.2

9.6

L04AB05

ATC

certolizumab pegol; parenteral

90.2

9.6

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.8

9.5

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

17.6

9.5

M01AB16

ATC

aceclofenac; oral

17.6

9.5

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

17.6

9.5

M89.0

ICD-10 Finland

Algoneurodystrophy

17.6

9.5

L02AE02

ATC

leuprorelin; implant, parenteral

2.7

9.5

210

J02

ICD-10 Finland

Acute pharyngitis

2.9

9.5

171

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

14.6

9.5

NHE15

NOMESCO Finland

Suture or reinsertion of ligament of ankle

14.6

9.5

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

14.6

9.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

9.5

113

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.4

9.5

272

D07BC01

ATC

betamethasone and antiseptics; topical

2.2

9.5

359

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.2

9.4

127

H03AA01

ATC

levothyroxine sodium; systemic

1.9

9.4

135

593

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

9.4

334

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

9.4

160

ND1AA

SPAT

8.7

9.3

SPAT1262

SPAT

Handing over of treatment supplies

2.1

9.3

103

405

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

26.7

9.3

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

10.6

9.3

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.1

9.3

106

425

SPAT1167

SPAT

Insertion of urinary catheter

4.1

9.3

N76.0

ICD-10 Finland

Acute vaginitis

2.2

9.3

368

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

7.9

9.3

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

3.4

9.2

111

N06AA12

ATC

doxepin; systemic

3.2

9.2

120

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.3

9.2

297

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

11.6

9.2

Z72.0

ICD-10 Finland

Tobacco use

5.2

9.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.2

9.2

381

WX400

NOMESCO Finland

Inhalation anesthesy

3.8

9.2

E66

ICD-10 Finland

Obesity

4.1

9.2

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

3.5

9.2

103

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

19.1

9.2

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

9.1

148

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

3.1

9.1

130

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.9

9.1

127

550

S01BC05

ATC

ketorolac; ophthalmic

2.7

9.1

199

M01AE51

ATC

ibuprofen, combinations; systemic

15.4

9.1

C10AA04

ATC

fluvastatin; oral

2.7

9.1

186

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.9

9.1

127

552

N05AX08

ATC

risperidone; systemic

1.8

9.1

149

685

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

9.1

170

817

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.1

9.1

388

F32

ICD-10 Finland

Depressive episode

2.2

9.1

329

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.3

9.0

113

M16.7

ICD-10 Finland

Other secondary coxarthrosis

32.8

9.0

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

32.8

9.0

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.9

9.0

143

649

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

6.2

9.0

OAA81

SPAT

6.5

9.0

T74.1

ICD-10 Finland

Physical abuse

3.6

9.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

8.9

291

N17

ICPC

Vertigo/dizziness

2.0

8.9

109

451

R01AD11

ATC

triamcinolone; nasal

2.4

8.8

261

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

21.3

8.8

XA402

NOMESCO Finland

ENMG

11.9

8.8

Z01.7

ICD-10 Finland

Laboratory examination

2.1

8.8

102

413

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.6

8.7

202

M62.6

ICD-10 Finland

Muscle strain

3.8

8.7

K92.1

ICD-10 Finland

Melaena

2.4

8.7

265

D03

ICPC

Heartburn

3.2

8.7

117

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

+∞

8.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.0

8.7

134

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

8.2

8.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

8.6

C10AA07

ATC

rosuvastatin; oral

2.9

8.6

141

L10

ICPC

Elbow symptom/complaint

3.3

8.5

105

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.9

8.5

154

C05AA01

ATC

hydrocortisone; rectal, topical

3.2

8.5

114

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

8.5

375

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.3

8.5

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.8

8.5

161

H29

ICPC

Ear symptom/complaint other

2.1

8.5

378

H53.1

ICD-10 Finland

Subjective visual disturbances

3.0

8.4

132

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1.9

8.4

125

553

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

5.9

8.4

M77.0

ICD-10 Finland

Medial epicondylitis

12.3

8.4

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

12.3

8.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.2

8.4

R03AC03

ATC

terbutaline; inhalant

1.8

8.4

148

696

ND2BA

SPAT

6.6

8.4

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.6

8.4

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

6.6

8.4

N20.1

ICD-10 Finland

Calculus of ureter

4.3

8.4

M01CB01

ATC

sodium aurothiomalate; parenteral

17.8

8.4

M75.5

ICD-10 Finland

Bursitis of shoulder

17.8

8.4

W17

ICD-10 Finland

Other fall from one level to another

2.4

8.4

253

S90.1

ICD-10 Finland

Contusion of toe(s) without damage to nail

3.7

8.4

R30.0

ICD-10 Finland

Dysuria

3.1

8.3

116

N30

ICD-10 Finland

Cystitis

2.2

8.3

306

M19.9

ICD-10 Finland

Arthrosis, unspecified

9.3

8.3

TAB00

NOMESCO Finland

Lumbar puncture

3.2

8.3

112

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

8.3

193

S83.0

ICD-10 Finland

Dislocation of patella

3.1

8.3

117

S20.2

ICD-10 Finland

Contusion of thorax

3.0

8.2

130

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

8.2

A11

ICPC

Chest pain NOS

2.9

8.2

148

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

8.2

250

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.2

8.2

113

N06AX26

ATC

vortioxetine; oral

2.2

8.2

332

U05

ICPC

Urination problems other

3.5

8.2

J37.0

ICD-10 Finland

Chronic laryngitis

6.0

8.2

NH1BG

SPAT

10.1

8.2

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.7

8.2

162

792

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

7.4

8.2

N03AX09

ATC

lamotrigine; oral

2.5

8.2

219

S43.1

ICD-10 Finland

Dislocation of acromioclavicular joint

6.9

8.2

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.9

8.1

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

8.1

227

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

2.2

8.1

297

N06AX12

ATC

bupropion; oral

2.1

8.1

387

F43.00

ICD-10 Finland

Acute stress reaction mild

4.1

8.1

R03BA08

ATC

ciclesonide; inhalant

2.9

8.0

138

XF402

NOMESCO Finland

ECG with work load test

2.7

8.0

165

D06BX01

ATC

metronidazole; topical

2.7

8.0

166

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

12.8

8.0

1221

FHL

Arthroscopy and meniscus surgery

7.8

8.0

-1

NOMESCO Finland

1.4

8.0

556

3595

R25.2

ICD-10 Finland

Cramp and spasm

6.2

8.0

M70.2

ICD-10 Finland

Olecranon bursitis

6.2

8.0

R13

ICD-10 Finland

Dysphagia

2.8

8.0

153

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

7.1

7.9

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

15.2

7.9

S29

ICPC

Skin symptom/complaint other

1.7

7.9

179

907

M81.9

ICD-10 Finland

Osteoporosis, unspecified

6.6

7.9

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.4

7.9

243

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.6

7.9

188

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5600

17822

1.95

311.44

2.5

2.6

u/l

57.0

59.5

1.48

5152

16498

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7069

24384

1.86

308.36

2.1

1.9

pmol/l

95.6

93.0

4.11

3785

13374

(3010813) Leukocytes [#/volume] in Blood

17705

80862

3.06

307.65

23.0

18.4

e9/l

6.9

6.8

8.19

17322

77560

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15290

65137

2.21

307.65

4.2

3.7

mmol/l

1.4

35.24

14174

60298

(3021601) Nitrite [Presence] in Urine by Test strip

8812

30671

1.98

307.65

5.0

4.7

estimate

0.0

0.50

1864

5931

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12733

48537

2.17

307.65

4.0

3.5

pmol/l

14.7

14.8

4.37

11671

43561

(3022096) Basophils/100 leukocytes in Blood

8546

28245

2.10

307.65

6.3

6.4

0.7

0.6

3.44

7998

26359

(3019069) Monocytes/100 leukocytes in Blood

8806

29228

2.11

307.65

6.6

6.7

8.5

8.6

3.27

8265

27350

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4202

5604

4.83

307.65

1.3

1.2

iu/ml

27.8

35.5

0.94

1278

1669

(40768797) Stomach Pathology biopsy report

2662

5902

2.63

307.65

1.2

—

(3044889) 12 lead EKG panel

11381

41573

2.12

307.65

3.7

3.6

—

(3006504) Eosinophils/100 leukocytes in Blood

8766

29101

2.11

307.65

6.3

6.4

2.8

0.09

8188

27148

(3013826) Glucose [Moles/volume] in Serum or Plasma

10127

36866

1.98

307.65

4.3

5.2

mmol/l

6.6

6.8

19.83

9482

33388

(3018010) Neutrophils/100 leukocytes in Blood

8936

29794

2.11

307.65

6.1

6.2

57.4

58.2

7.79

8375

27892

(3037467) Urinalysis macro (dipstick) panel - Urine

12304

43743

2.38

307.65

4.6

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5350

16454

2.01

307.65

2.1

2.2

u/l

184.5

265.2

5.49

5016

15440

(3031040) Bacteria [#/volume] in Urine by Automated count

11437

42006

2.11

307.65

4.8

4.0

e6/l

1165.0

1463.5

0.21

156

707

(3037522) Nuclear Ab [Titer] in Serum

3116

6090

3.06

307.65

1.4

1.3

titre

470.4

539.3

1.05

604

1219

(3024731) MCV [Entitic volume]

17694

80844

3.04

307.65

22.9

18.3

90.9

90.3

59.21

17490

79155

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15375

65731

2.22

307.65

4.3

3.7

mmol/l

4.6

1.75

14322

61036

(40761511) CBC panel - Blood by Automated count

16847

72777

2.86

307.65

14.6

12.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

9033

30378

2.10

307.65

6.4

28.0

27.1

9.84

8426

28351

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4014

4991

5.15

307.65

1.3

1.2

u/ml

10.6

12.0

0.32

1584

1764

(3019198) Lymphocytes [#/volume] in Blood

9490

31635

2.18

307.65

6.1

6.2

e9/l

2.0

1.9

2.70

8433

27753

(3013707) Erythrocyte sedimentation rate by Westergren method

13479

41695

3.40

307.65

4.8

3.2

mm/h

11.2

12.8

26.08

12635

38063

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8233

28893

1.90

307.65

4.1

4.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8847

30433

2.01

307.65

5.3

6.3

umol/l

11.2

12.4

11.93

8310

28766

(3000963) Hemoglobin [Mass/volume] in Blood

17701

80905

3.05

307.65

23.1

18.5

g/l

136.1

135.2

11.62

17500

79243

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17114

73627

3.14

307.65

11.1

8.5

u/l

27.3

26.0

7.61

16582

70467

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7141

24261

1.90

307.65

2.3

nmol/l

75.5

74.4

2.33

6409

21974

(3026361) Erythrocytes [#/volume] in Blood

17698

80853

3.05

307.65

23.0

18.3

e12/l

4.5

0.23

17312

77575

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14591

57751

2.43

307.65

5.7

5.2

mmol/mol

39.3

39.6

3.42

13577

53213

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6731

21215

2.06

307.65

3.7

3.6

ng/l

143.7

76.1

0.40

4276

15013

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17085

72647

3.24

307.65

17.3

14.9

umol/l

78.8

81.2

17.32

17079

72587

(3023103) Potassium [Moles/volume] in Serum or Plasma

16548

67951

3.11

307.65

16.9

15.8

mmol/l

4.0

10.83

16158

65369

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4328

10699

2.49

307.65

1.8

2.0

mg/l

1.1

1.7

18.57

3242

8144

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8385

29832

1.88

307.65

5.5

8.1

mmol/l

1.2

7.00

6963

24938

(3013115) Eosinophils [#/volume] in Blood

9558

31475

2.22

307.65

6.2

6.7

e9/l

0.2

0.61

8464

27543

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13359

46244

2.76

307.65

7.2

7.5

u/l

75.7

80.0

16.85

12599

43313

(3019550) Sodium [Moles/volume] in Serum or Plasma

16506

67759

3.08

307.65

16.8

15.7

mmol/l

139.6

139.5

5.12

16138

65316

(3035350) Ketones [Presence] in Urine by Test strip

8823

30565

1.99

307.65

3.7

3.4

estimate

0.0

1.54

1821

5793

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14974

59821

2.50

307.65

4.8

4.0

mu/l

2.1

2.3

0.48

13821

54577

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15656

67026

2.30

307.65

4.7

4.1

mmol/l

2.7

1.18

14470

61793

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11460

43643

1.98

307.65

3.2

2.7

u/l

47.8

44.8

2.56

10717

40796

(3006315) Basophils [#/volume] in Blood

9283

30479

2.20

307.65

6.1

6.2

e9/l

0.0

4.63

8123

26335

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15343

61081

2.66

307.65

14.0

12.6

ml/min/173m2

84.6

82.7

15.03

13128

47793

(3035941) MCH [Entitic mass]

17698

80825

3.06

307.65

22.9

18.3

30.3

30.1

40.34

17494

79141

(3007461) Platelets [#/volume] in Blood

17685

80680

3.05

307.65

23.0

18.4

e9/l

250.9

247.2

11.30

17356

77655

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14832

62517

2.15

307.65

3.8

3.4

mmol/l

1.3

1.2

42.27

13654

57620

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16821

65931

3.84

307.65

16.0

13.0

mg/l

22.0

26.8

54.61

14120

49473

(3009261) Glucose [Presence] in Urine by Test strip

8931

30962

2.00

307.65

3.7

3.4

estimate

0.0

0.48

1806

5748

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15250

63253

2.36

307.65

4.5

3.9

mmol/l

5.9

0.79

13950

57565

(3008898) HLA-B27 [Presence]

1325

1043

7.19

307.65

1.1

1.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

5583

12275

3.00

307.65

2.6

3.1

umol/l

4180.7

5887.4

1.77

4831

10769

(3001604) Monocytes [#/volume] in Blood

9227

30348

2.19

307.65

6.1

6.2

e9/l

0.6

0.06

8081

26175

(42870588) Differential panel, method unspecified - Blood

6576

20612

2.06

307.65

6.0

6.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7593

26399

1.88

307.65

4.9

7.3

mmol/l

1.2

9.70

6827

23940

(3013650) Neutrophils [#/volume] in Blood by Automated count

10332

35397

2.20

307.65

8.2

10.3

e9/l

4.2

4.3

0.63

9075

30823

(3009542) Hematocrit [Volume Fraction] of Blood

15126

66406

1.99

303.37

16.2

13.9

40.3

39.3

30.47

11364

47690

(40768804) Tissue Pathology biopsy report

6596

22372

1.87

301.46

2.1

2.0

—

(3018095) Leukocytes [#/volume] in Urine

6458

21792

1.87

299.35

3.8

3.9

e6/l

78.1

128.8

4.87

4616

15376

(3015736) pH of Urine

6879

23792

1.84

294.03

3.4

3.2

5.7

6.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

673

614

6.01

283.34

1.8

1.5

e6/l

12106.1

14640.8

0.54

465

445

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2331

5429

2.46

274.90

1.5

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

748

790

5.20

274.76

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5681

18813

1.86

273.80

2.9

3.5

mmol/l

2.3

0.98

4938

16448

(3024561) Albumin [Mass/volume] in Serum or Plasma

7331

26343

1.78

270.83

4.2

5.7

g/l

35.9

35.0

32.98

6789

24409

(3044640) Blood type and Crossmatch panel - Blood

5597

18535

1.86

268.76

2.5

—

(3021788) Differential panel - Synovial fluid

560

443

6.90

265.13

1.6

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6186

21339

1.80

258.76

5.1

4.5

ug/l

2.9

4.8

3.79

5505

18940

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3770

11093

2.01

253.31

1.8

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6737

24013

1.76

250.72

3.9

3.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7889

29446

1.72

249.68

2.9

3.0

ug/l

121.1

125.1

0.54

7309

27353

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4175

12839

1.93

246.97

1.3

u/ml

1.4

2.1

3.20

1110

3373

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11309

46728

1.70

245.34

3.5

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

5542

18729

1.81

245.08

3.3

3.5

e6/l

58.4

120.0

2.84

4320

14456

(3032080) INR in Blood by Coagulation assay

6910

25103

1.73

237.37

7.8

12.7

inr

1.2

1.4

52.61

2085

7595

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4334

13657

1.89

237.24

2.4

—

(36304419) Bacteria [Presence] in Urine

4924

16213

1.83

234.94

3.1

3.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1490

3019

2.76

228.05

2.4

2.3

au/ml

22.2

21.7

0.05

166

(3030467) Casts [#/volume] in Urine by Automated count

5028

16802

1.80

227.49

3.2

3.4

e6/l

0.4

0.5

3.13

3855

12733

(3007164) IgA [Mass/volume] in Serum or Plasma

3667

11142

1.93

221.57

1.5

1.4

g/l

2.3

2.4

2.40

2275

6925

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4932

16511

1.79

220.66

4.3

4.0

21.8

22.4

1.83

2274

8269

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1374

2715

2.82

219.64

1.3

1.2

au/ml

35.6

59.6

2.39

111

(40760892) CBC W Ordered Manual Differential panel - Blood

4270

13695

1.85

218.90

4.4

4.9

—

(3013512) EKG study

4848

16254

1.79

214.86

3.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3691

11443

1.89

208.65

3.2

2.9

ug/l

0.8

0.9

7.04

2389

7782

(3021589) Normoblasts [#/volume] in Blood

7642

29254

1.65

208.60

10.1

9.8

e9/l

0.0

0.49

6319

24035

(3048689) Calprotectin [Mass/mass] in Stool

2543

6936

2.10

204.73

2.4

3.1

ug/g

124.6

157.1

3.64

2024

5548

(3000850) Epithelial cells [#/volume] in Urine

3994

12773

1.84

204.71

2.5

2.9

e6/l

5.1

5.4

0.65

3510

11204

(3000492) Spirometry study

1953

4774

2.31

204.25

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5032

17387

1.73

198.49

3.3

3.2

—

(3002385) Erythrocyte distribution width [Ratio]

13506

60061

1.66

197.77

18.3

16.2

13.6

0.23

13252

58434

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4761

16287

1.74

193.64

2.9

3.4

ng/l

1409.1

2202.2

23.94

3922

14254

(3023368) Bacteria identified in Blood by Culture

4940

17181

1.71

188.70

4.1

4.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

4132

13737

1.77

183.91

1.6

1.5

nmol/l

20.1

19.3

2.37

3565

12057

(3042936) Bacteria identified in Isolate by Culture

2730

8000

1.95

179.29

2.0

2.1

—

(3044941) Cell count panel - Synovial fluid

445

429

5.63

177.88

1.5

1.3

—

(40758558) Short blood count panel - Blood

4381

14959

1.72

176.76

6.2

7.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

900

1569

3.15

176.26

1.2

u/ml

1.1

1.2

0.07

121

(3033658) Prothrombin time (PT) actual/Normal

4341

14868

1.72

172.62

3.8

4.4

90.0

85.0

28.86

4231

14502

(3018418) pH of Serum or Plasma

4982

17726

1.67

172.21

3.3

5.2

7.4

1.63

1028

3523

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4715

16545

1.68

171.52

2.3

mg/l

2.9

3.0

0.96

3986

14107

(3011397) Hemoglobin [Presence] in Urine by Test strip

4026

13710

1.71

161.91

3.7

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

4659

16598

1.65

157.85

4.1

3.6

estimate

0.0

1.01

1811

5514

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

895

1673

2.94

156.27

1.6

iu/ml

8.6

2.8

0.39

166

423

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3079

9790

1.80

155.78

2.8

3.2

mmol/l

2.4

2.24

2666

8441

(3003338) MCHC [Mass/volume]

13668

62471

1.57

152.82

19.2

16.2

g/l

332.8

0.13

13559

61694

(1002224) Polysomnography panel

853

1578

2.96

151.49

1.1

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

2268

6629

1.93

147.94

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1731

4593

2.11

146.63

2.3

1.9

nmol/l

12.3

12.0

0.57

1515

4074

(3026470) Cobalt [Mass/volume] in Blood

175

20.88

146.47

2.0

1.6

ug/l

3.4

1.9

1.98

154

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

350

331

5.71

142.32

1.7

1.5

58.2

62.0

0.67

211

224

(3025577) Chromium [Mass/volume] in Blood

170

20.74

142.01

2.1

1.7

ug/l

2.0

1.6

0.63

143

(3019225) pH of Specimen

1793

4918

2.04

139.01

3.8

5.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5606

21448

1.55

137.99

2.9

3.2

u/l

35.1

33.9

0.16

5289

20289

(3009508) Creatinine [Moles/volume] in Urine

5139

19355

1.56

134.86

3.2

3.5

mmol/l

8.0

7.7

5.29

4264

16462

(3022145) Colonoscopy Study observation

1997

5756

1.94

134.84

1.3

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1407

3579

2.18

131.75

2.6

3.4

e9/l

4.3

4.2

0.26

1087

2771

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

696

1250

3.04

129.54

1.8

2.1

—

(3026782) Osmolality of Urine

3642

12720

1.65

129.39

2.7

3.1

mosm/kgh2o

555.2

551.2

0.44

3117

10866

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3005

10045

1.70

125.35

2.8

2.9

e6/l

1.0

1.2

1.17

1670

5812

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1746

4952

1.96

122.82

2.0

2.2

nmol/l

363.8

400.2

10.37

1593

4570

(3001019) Free T4 and TSH panel - Serum or Plasma

1027

2363

2.39

120.48

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

2040

6155

1.85

119.42

1.4

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3302

11457

1.64

119.16

3.8

3.7

ng/l

288.4

666.6

8.17

2485

9069

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3658

13058

1.61

117.73

1.7

pmol/l

38769859.2

28338073.9

0.43

3023

10816

(3025941) Bacteria identified in Stool by Culture

1244

3165

2.17

115.98

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

595

1052

3.07

113.46

1.2

1.3

u/ml

22.8

46.3

0.94

(3026008) Bacteria identified in Urine by Culture

4981

19237

1.51

112.73

3.2

2.9

—

(3012516) Albumin [Mass/volume] in Urine

4544

17232

1.53

111.76

3.1

3.7

mg/l

440.2

410.9

0.14

2924

11554

(36660697) Celiac disease serology panel - Serum

1572

4437

1.96

111.63

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2035

6267

1.81

111.22

6.8

7.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2018

6205

1.82

110.82

4.2

4.1

31.7

32.7

3.55

1407

4235

(3019309) Folate [Moles/volume] in Red Blood Cells

3302

11683

1.61

109.18

1.8

nmol/l

1132.2

1160.2

0.92

2436

8829

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

555

971

3.10

107.60

1.2

1.3

u/ml

8.5

9.5

0.10

149

(3020682) Albumin/Creatinine [Ratio] in Urine

4772

18439

1.50

106.64

3.9

4.5

mg/mmol

8.6

12.4

5.66

3059

12532

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2848

9773

1.65

105.98

3.0

3.1

e6/l

2.2

2.6

1.39

1520

5562

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

546

957

3.10

105.54

1.2

1.3

u/ml

2.9

12.8

1.10

(1761868) Lipid panel - Serum or Plasma

5748

23167

1.46

103.52

2.7

2.6

—

(4010399)

1214

3200

2.09

103.30

1.4

—

(3002256) Pathology report gross observation

2155

6904

1.74

102.79

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1193

3130

2.10

102.71

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

550

985

3.03

102.69

2.0

1.6

pmol/l

199.6

190.8

0.76

517

934

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2779

9551

1.64

102.47

2.3

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

766

1654

2.53

102.19

1.9

1.5

nmol/l

37.9

44.7

10.09

747

1627

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3022

10629

1.61

101.57

2.4

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

1201

3206

2.06

98.79

1.3

u/ml

199.2

356.5

4.66

1101

2958

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2894

10136

1.61

98.65

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2439

8210

1.67

96.94

1.9

1.7

1.4

0.23

2161

7301

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

256

262

5.26

96.69

1.5

1.4

32.0

27.9

0.68

148

183

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4017

15275

1.51

95.07

1.6

mmol/l

1.4

1.3

8.61

3376

13054

(3019150) Specific gravity of Urine by Refractometry

3695

13886

1.52

92.01

4.1

3.5

kg/l

1.0

0.19

532

2471

(40761535) Cells panel - Urine sediment

1443

4223

1.89

91.56

3.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

323

440

3.96

89.03

1.3

1.6

iu/ml

21.7

33.0

0.98

(3010144) Erythrocytes [#/volume] in Synovial fluid

238

252

5.08

86.96

1.5

1.3

e6/l

62590.5

84668.8

0.26

161

168

(3005719) IgG [Mass/volume] in Serum or Plasma

1415

4262

1.83

81.84

2.4

2.8

g/l

10.4

10.9

4.06

1274

3916

(3002179) Metamyelocytes/100 leukocytes in Blood

1553

4815

1.78

81.78

3.7

4.5

0.6

0.7

0.33

322

1146

(3021440) Promyelocytes/100 leukocytes in Blood

1617

5081

1.76

81.39

4.0

4.7

0.1

0.07

402

1494

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1653

5229

1.75

81.32

2.4

2.6

u/l

34.0

38.8

1.45

1424

4526

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

444

805

2.98

81.21

1.2

1.3

u/ml

32.5

35.6

0.12

(3020961) Endomysium IgA Ab [Titer] in Serum

956

2524

2.07

80.57

1.1

titre

308.9

206.5

—

100

(3025159) Blasts/100 leukocytes in Blood

1532

4769

1.77

79.51

4.0

4.8

0.0

0.1

3.54

349

1252

(3017181) Myelocytes/100 leukocytes in Blood

1677

5369

1.73

79.03

3.9

4.7

0.8

0.9

0.12

427

1593

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1871

6203

1.67

77.61

3.4

3.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

351

566

3.34

77.04

1.1

1.2

iu/ml

1.9

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

383

656

3.15

76.74

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1969

6636

1.65

76.68

2.5

2.9

umol/l

8.1

10.1

2.99

1672

5756

(3003740) Influenza virus B Ag [Presence] in Specimen

382

658

3.13

75.87

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

967

2646

2.00

73.99

2.4

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1027

2888

1.94

72.78

1.1

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

428

816

2.83

71.89

1.2

u/ml

0.6

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

420

806

2.81

69.75

1.2

1.3

u/ml

4.9

11.1

0.57

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

708

1768

2.17

68.46

1.6

1.7

—

(40768443) Skin Pathology biopsy report

816

2173

2.04

67.07

1.2

—

(3045414) Leukocytes [Presence] in Urine

859

2333

2.00

66.98

1.8

1.9

—

(40761536) Microorganisms panel - Urine sediment

1667

5569

1.65

66.67

3.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1188

3607

1.80

66.56

2.1

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

628

1515

2.25

65.86

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

630

1523

2.24

65.75

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

623

1507

2.24

64.92

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1452

4707

1.69

64.92

2.1

2.4

g/l

66.5

65.9

2.26

1316

4289

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

428

864

2.67

64.88

1.6

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

270

413

3.52

63.95

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1480

4844

1.68

63.84

2.3

ug/l

6.1

9.6

8.58

1231

4205

(3022948) Iron [Moles/volume] in Serum or Plasma

2807

10675

1.47

63.19

2.1

3.1

umol/l

13.1

12.7

2.21

2577

9903

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

804

2183

2.00

62.70

1.8

1.9

u/l

38.3

38.1

0.10

720

1907

(3003327) Ova and parasites identified in Stool by Light microscopy

708

1853

2.07

60.84

1.6

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

144

131

5.89

60.77

1.4

6.4

2.8

1.19

(3024891) Influenza virus A+B Ag [Presence] in Specimen

584

1414

2.24

60.71

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

559

1328

2.28

60.70

1.5

1.4

ug/g

283.3

256.4

1.87

316

786

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

499

1139

2.37

59.18

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1396

4591

1.67

58.99

1.6

1.8

—

(4094501)

453

995

2.46

58.25

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

740

2016

1.99

57.13

3.3

4.7

mmol/l

24.7

24.5

0.56

688

1836

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

521

1233

2.28

57.07

1.4

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1190

3787

1.72

56.63

3.0

4.1

kpa

5.2

5.1

1.09

1083

3523

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

815

2312

1.92

56.11

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2641

10185

1.44

54.55

2.8

3.9

mmol/l

0.8

0.89

2433

9511

(3028026) IgM [Mass/volume] in Serum or Plasma

1076

3369

1.74

54.15

1.8

1.9

g/l

1.3

1.4

0.69

970

3079

(3009343) pH of Capillary blood

1169

3754

1.70

53.79

3.0

4.1

7.4

0.23

158

586

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2581

9976

1.44

52.50

2.1

3.1

g/l

2.3

2.80

2362

9261

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

748

2119

1.91

51.67

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2452

9418

1.44

51.50

1.5

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1653

5865

1.55

50.96

1.3

1.5

—

(3022313) Gas panel - Capillary blood

835

2468

1.84

50.73

3.1

4.4

—

(3024263) Appearance of Synovial fluid

137

144

5.09

50.58

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1125

3654

1.68

49.57

2.9

4.0

mmol/l

1.7

0.08

834

2616

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

595

1584

2.03

48.87

1.6

1.8

g/l

1.2

1.1

4.50

557

1504

(3004716) Salmonella sp identified in Stool by Organism specific culture

1048

3371

1.69

47.82

1.3

1.4

—

(40762814) Titanium [Mass/volume] in Blood

24.02

47.11

2.3

2.1

ug/l

4.1

2.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1994

7483

1.47

46.94

2.4

2.9

1.8

1.7

0.40

1716

6614

(21494755) Public health laboratory ask at order entry panel

1820

6713

1.49

46.67

1.3

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1914

7145

1.47

46.23

1.7

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

578

1556

2.01

46.07

1.6

1.8

g/l

0.2

0.05

542

1475

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2388

9303

1.42

46.03

2.2

3.3

23.1

22.4

1.17

2036

7830

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

278

537

2.78

45.75

2.0

1.9

mg/l

30.6

30.4

0.02

124

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

661

1873

1.91

45.61

2.1

2.3

g/l

3.1

0.23

534

1433

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1918

7204

1.46

44.84

1.7

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

703

2050

1.86

44.50

2.1

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

605

1678

1.95

44.40

2.2

2.4

g/l

0.8

1.0

0.36

527

1431

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

703

2054

1.85

44.23

2.1

2.2

g/l

7.4

7.3

0.91

540

1455

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

701

2050

1.85

43.98

2.1

2.2

g/l

3.8

0.54

520

1398

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1035

3400

1.66

43.60

2.5

2.3

u/l

6190.9

8012.6

0.83

356

1478

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1058

3509

1.64

42.94

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

363

834

2.34

42.52

1.7

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2190

8515

1.42

42.42

21.1

31.9

inr

1.3

1.6

15.54

372

952

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

555

1524

1.97

41.90

2.0

2.1

g/l

38.1

36.9

3.88

482

1306

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

287

592

2.60

41.89

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

174

264

3.53

41.84

1.1

1.2

u/ml

29.4

27.2

—

(3015183) Erythrocyte sedimentation rate

151

206

3.92

41.76

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

546

1495

1.97

41.55

2.1

2.2

g/l

0.0

0.25

500

1354

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

503

1337

2.03

41.50

1.3

mg/l

479.3

541.3

1.44

472

1267

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

437

1103

2.13

41.17

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

697

2078

1.82

41.16

1.4

u/l

7.8

8.7

1.35

583

1668

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

158

228

3.71

40.67

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

653

1915

1.84

40.61

2.1

2.2

g/l

10.0

10.8

3.87

563

1587

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

169

257

3.52

40.52

1.1

1.2

u/ml

59.9

18.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

807

2527

1.73

40.45

1.3

1.4

iu/l

19.7

23.0

2.24

699

2101

(3049717) Cytology report of Urine Cyto stain

731

2234

1.77

39.81

2.7

2.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

500

1348

2.00

39.72

2.1

2.2

g/l

0.0

0.00

458

1236

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

188

313

3.22

39.54

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1451

5278

1.50

39.51

3.1

4.6

mmol/l

1.2

0.02

1263

4645

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

123

148

4.45

39.48

1.9

2.4

mg/l

8.6

9.5

0.62

118

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

188

314

3.21

39.35

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

188

315

3.20

39.17

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

504

1370

1.98

39.15

2.1

2.2

g/l

0.0

1.18

459

1239

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2406

9653

1.37

38.51

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

803

2546

1.71

38.50

1.5

1.7

u/ml

15.2

13.3

0.13

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

159

242

3.52

38.11

1.1

1.2

u/ml

2.3

24.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1528

5661

1.47

38.00

6.0

7.7

mmol/l

1.4

0.92

1457

5415

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

311

3.17

37.84

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

185

314

3.16

37.80

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

184

314

3.14

37.29

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1273

4558

1.52

37.27

2.6

3.0

ml/min/173m2

69.4

62.7

5.62

476

1905

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1048

3591

1.59

37.21

3.1

3.6

pmol/l

4.6

4.5

1.38

917

3219

(3047007) Chlamydophila sp Ab [Presence] in Serum

276

595

2.49

37.00

1.2

—

(3022621) pH of Urine by Test strip

1178

4155

1.54

36.91

2.9

2.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

116

141

4.40

36.84

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1189

4208

1.54

36.69

1.2

iu/ml

130.4

148.1

0.79

446

1562

(3005988) Vibrio sp identified in Specimen by Organism specific culture

268

573

2.51

36.53

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

444

1183

2.02

36.43

1.2

1.3

mmol/l

3.7

3.9

2.67

415

1109

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

267

573

2.50

36.13

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

568

1655

1.85

36.05

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

266

572

2.50

35.85

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

273

598

2.45

35.45

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

268

582

2.47

35.42

1.4

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

563

1647

1.84

35.30

1.1

u/ml

2.1

8.2

4.37

191

(3036670) Protein [Mass/volume] in Synovial fluid

5.76

34.59

1.2

g/l

38.7

40.4

0.36

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1945

7660

1.39

34.57

3.6

4.6

u/l

231.1

249.7

7.95

1805

7320

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

633

1943

1.76

33.97

1.6

1.7

titre

237.2

308.3

0.28

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

289

665

2.33

33.83

1.1

au/ml

10.4

16.4

0.60

(3024522) Salmonella sp identified in Specimen by Organism specific culture

265

586

2.43

33.76

1.4

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1879

7396

1.39

33.45

1.7

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

1457

5479

1.45

33.43

2.5

2.8

e9/l

69.8

67.4

1.49

1047

4138

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1484

5635

1.44

32.30

2.1

2.4

g/l

0.2

6.23

1371

5205

(44816559) Phosphatidylethanol [Mass/volume] in Blood

420

1152

1.96

31.87

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

722

2346

1.66

31.63

1.1

u/ml

18.9

6.5

0.29

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

477

1378

1.86

31.12

1.8

2.0

mg/l

10.7

12.1

2.17

437

1288

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

134

211

3.40

30.71

1.5

u/l

6.9

7.0

0.03

114

173

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1080

3889

1.51

30.68

6.0

8.3

mmol/l

24.9

24.5

2.83

1073

3846

(3014576) Chloride [Moles/volume] in Serum or Plasma

2026

8190

1.35

30.44

6.2

7.7

mmol/l

104.7

104.3

3.21

1983

7997

(3044290) Cell count panel - Cerebral spinal fluid

406

1123

1.94

30.11

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1562

6076

1.40

29.64

1.7

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

112

4.39

29.26

1.8

1.9

au/ml

200.4

97.6

0.73

(3045424) Erythrocytes [Presence] in Urine

327

844

2.08

29.24

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

239

541

2.37

29.06

1.3

u/ml

62.1

52.2

0.15

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

206

438

2.52

28.51

1.1

mg/l

240.7

288.4

1.36

177

378

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

418

1198

1.88

27.97

1.3

1.5

e6/l

1191.0

1265.5

0.04

335

977

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

566

1781

1.71

27.91

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

418

1199

1.87

27.90

1.3

1.5

e6/l

12.1

44.2

2.34

316

926

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

211

460

2.46

27.78

1.2

1.1

mg/l

38.4

53.3

2.00

172

382

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

296

751

2.12

27.67

1.0

1.1

u/ml

1.6

3.2

2.10

131

339

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

526

1647

1.72

26.41

1.3

1.6

iu/ml

10.8

8.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

842

2971

1.53

26.25

2.6

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

196

429

2.45

25.63

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

140

258

2.90

25.22

1.1

nmol/l

6.1

7.4

0.14

(3014051) Protein [Presence] in Urine by Test strip

424

1264

1.80

25.14

2.0

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

143

269

2.84

24.88

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1814

7438

1.33

24.53

6.2

7.8

kpa

12.2

12.4

1.16

1721

7063

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1814

7442

1.33

24.44

6.2

7.8

kpa

5.1

5.0

2.89

1723

7067

(3011288) Drugs identified in Urine by Screen method

732

2547

1.55

24.29

3.9

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1059

3980

1.44

24.22

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2399

10235

1.28

24.22

2.0

2.4

29.9

30.3

2.60

2325

9926

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

298

799

2.00

24.19

1.5

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

4.62

24.00

1.4

1.3

54.5

68.1

1.74

(3016879) Cocaine [Presence] in Urine

969

3588

1.46

23.95

2.5

2.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

381

1118

1.83

23.78

1.2

titre

202.9

79.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

643

2182

1.59

23.76

2.0

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

4.66

23.55

1.5

1.3

32.6

36.7

0.28

(3024980) IgG subclass 4 [Mass/volume] in Serum

316

874

1.94

23.54

1.4

1.7

g/l

0.7

0.8

1.75

237

663

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

293

792

1.98

23.28

1.3

1.4

u/l

17.5

21.7

1.58

243

660

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

342

2.55

23.25

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1029

3876

1.44

23.25

2.5

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

293

794

1.98

23.12

1.1

u/ml

6.7

5.6

0.37

112

375

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

163

344

2.54

22.99

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1363

5402

1.37

22.96

3.1

3.3

ng/l

226.1

296.2

5.14

1211

4952

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

255

658

2.08

22.93

1.1

u/ml

0.1

0.5

1.92

147

(3028300) Cannabinoids [Presence] in Urine

1034

3910

1.43

22.87

2.5

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

483

1541

1.69

22.72

3.4

2.8

—

(3003396) Base excess in Arterial blood by calculation

1798

7448

1.31

22.56

6.2

7.8

mmol/l

0.9

1.0

0.65

1364

5705

(3027008) Opiates [Presence] in Urine

1030

3904

1.43

22.49

2.5

1.9

—

(4062490)

218

535

2.18

22.21

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

303

847

1.92

21.93

1.1

u/ml

6.1

4.6

0.21

119

383

(3016018) Differential panel - Cerebral spinal fluid

223

556

2.15

21.87

1.2

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

113

201

3.00

21.66

1.0

iu/ml

10.0

8.5

0.19

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

212

520

2.18

21.64

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1306

5190

1.36

21.61

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

938

3539

1.43

21.00

2.7

3.0

e6/l

0.2

0.3

1.97

916

3479

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

399

1235

1.74

20.94

1.1

u/ml

1.6

2.3

0.80

159

574

(3027944) Amphetamines [Presence] in Urine

1006

3847

1.41

20.91

2.3

2.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

214

535

2.14

20.88

1.3

g/l

0.4

1.07

150

360

(3003888) Timothy IgE Ab [Units/volume] in Serum

363

1095

1.78

20.79

1.1

u/ml

7.5

7.2

0.08

184

614

(3027135) IgG subclass 1 [Mass/volume] in Serum

214

536

2.14

20.78

1.3

g/l

6.4

7.3

2.47

149

365

(3028192) IgG subclass 2 [Mass/volume] in Serum

214

536

2.14

20.78

1.3

g/l

3.0

3.2

0.72

151

364

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1586

6536

1.32

20.58

2.1

2.0

—

(3003694) ABO and Rh group [Type] in Blood

4675

21748

1.19

20.46

1.5

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

989

3793

1.41

20.22

8.1

10.4

93.9

93.7

0.45

984

3779

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2127

9130

1.27

20.21

3.9

8.5

mmol/l

1.0

1.1

5.46

1949

8524

(3016502) Oxygen saturation in Arterial blood

1595

6609

1.31

19.88

6.5

8.3

95.6

95.3

0.61

1532

6346

(3052851) Hemolysis interference index of Serum or Plasma

534

1811

1.59

19.83

2.9

3.6

—

(4027681)

161

364

2.37

19.80

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

345

1041

1.78

19.76

1.1

u/ml

1.6

1.4

0.11

137

494

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

6.00

19.59

1.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

891

3380

1.42

19.37

8.4

10.0

mmol/l

24.3

24.1

0.72

829

3136

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

128

3.42

19.21

1.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

992

3842

1.39

19.17

8.0

10.1

1.4

0.97

985

3812

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

126

3.43

19.07

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

990

3842

1.39

18.91

8.0

10.2

0.7

0.66

981

3818

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

424

1380

1.65

18.58

3.5

4.1

56.9

58.6

1.79

424

1380

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

200

511

2.09

18.54

1.5

1.3

pmol/l

201.2

70.4

0.50

117

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

221

2.73

18.50

2.7

2.3

umol/l

149.7

168.9

0.22

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

140

307

2.44

18.39

1.1

u/l

1.1

0.18

116

(3038177) Helicobacter pylori Ab [Presence] in Serum

297

876

1.82

18.35

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

1047

1.74

18.22

1.1

u/ml

3.1

2.6

0.24

297

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

240

661

1.94

18.21

1.3

nmol/l

0.6

1.6

0.85

229

635

(4024509)

172

418

2.20

18.03

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

240

665

1.93

17.91

1.3

nmol/l

0.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

415

1358

1.64

17.84

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

231

633

1.95

17.80

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

414

1358

1.64

17.63

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

9.66

17.62

1.2

1.1

mmol/l

6.5

6.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

786

2976

1.42

17.28

1.5

1.8

mu/l

288.8

369.6

3.71

710

2636

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1454

6068

1.30

17.14

6.9

8.8

g/l

123.3

120.1

6.51

1395

5832

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

658

2414

1.47

17.09

2.9

3.2

u/ml

49.2

80.0

1.71

630

2339

(3037121) Protein [Mass/volume] in Urine

597

2150

1.49

16.99

2.7

3.8

g/l

0.3

0.4

3.85

253

1143

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

533

1874

1.53

16.97

2.8

3.1

mg/l

65.7

51.8

0.23

431

1496

(4035726)

1219

4976

1.32

16.85

1.3

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

175

441

2.12

16.85

1.2

mmol/l

1.8

2.2

4.54

162

407

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

175

1801

0.51

16.78

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3909

18165

1.18

16.77

1.9

2.0

—

(3010421) pH of Blood

518

1816

1.53

16.72

3.6

4.7

7.4

0.49

452

1550

(3010375) cycloSPORINE [Mass/volume] in Blood

686

0.23

16.72

12.6

27.2

ug/l

96.2

102.2

0.26

585

(3026389) Candida sp identified in Specimen by Organism specific culture

257

747

1.84

16.67

1.5

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

902

6429

0.73

16.65

1.4

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

531

1878

1.52

16.47

2.8

3.1

mg/l

154.1

63.8

0.40

430

1499

(3035320) C reactive protein [Mass/volume] in Body fluid

148

354

2.24

16.16

2.7

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

500

1754

1.53

16.11

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

669

2493

1.44

16.05

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

432

3480

0.65

15.95

1.5

1.7

—

(44813793)

144

343

2.24

15.88

1.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

459

1588

1.55

15.74

3.7

4.7

kpa

5.0

0.58

451

1546

(3012501) Base excess in Blood by calculation

459

1588

1.55

15.74

3.7

4.7

mmol/l

2.4

2.7

1.26

295

1042

(3008757) Leukocyte morphology finding [Identifier] in Blood

220

620

1.90

15.70

3.0

4.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

518

1843

1.51

15.65

2.7

3.0

ratio

1.7

5.1

1.93

149

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1141

4674

1.32

15.38

2.8

5.7

ng/l

83.4

115.6

24.25

980

4079

(3027315) Oxygen [Partial pressure] in Blood

459

1598

1.54

15.32

3.7

4.7

kpa

8.7

8.6

0.19

451

1555

(3005570) Glucose [Moles/volume] in Urine

192

522

1.97

15.20

2.4

1.7

—

0.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

166

2.80

14.97

1.1

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

521

1882

1.49

14.67

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

128

302

2.26

14.48

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

162

422

2.05

14.42

1.6

2.2

nmol/l

19.5

19.7

0.11

151

407

(3042733) HLA Ab [Presence] in Serum

488

0.16

14.36

4.6

5.4

—

(40767503) Oxygen content in Capillary blood by calculation

423

1469

1.54

14.31

2.2

2.8

16.6

16.2

0.95

201

843

(3042517) Benzodiazepines panel - Urine

4.02

14.29

3.4

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

410

1415

1.55

14.26

1.9

iu/l

3.9

4.1

0.12

141

530

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

830

3284

1.36

14.12

1.7

2.0

g/l

1.5

1.4

1.77

708

2802

(3050129) First trimester maternal screen panel - Serum or Plasma

591

4386

0.71

14.07

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

201

571

1.88

14.07

3.0

3.8

61.9

58.9

0.85

124

353

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

210

608

1.85

13.88

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

458

1631

1.51

13.83

1.2

1.3

titre

94.8

91.1

0.07

158

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

196

2.56

13.78

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

286

910

1.68

13.78

1.3

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

203

2.52

13.70

1.1

1.0

u/ml

12.7

14.4

0.12

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.46

13.68

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.46

13.68

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.46

13.68

1.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

625

2374

1.41

13.57

1.5

1.6

mg/l

3.4

3.7

0.51

467

1433

(3006442) Creatine [Moles/volume] in Serum or Plasma

139

350

2.12

13.51

1.5

1.6

umol/l

64.4

71.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

228

684

1.78

13.48

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

384

3053

0.66

13.34

1.8

—

(3034770) Mitochondria Ab [Titer] in Serum

445

1590

1.50

13.25

1.2

1.3

titre

907.5

937.3

—

(3023410) Appearance of Cerebral spinal fluid

185

522

1.90

13.24

1.3

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

2.49

13.17

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

131

327

2.14

13.03

3.7

2.7

mu/l

27.5

20.6

1.21

119

296

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

203

2.47

12.89

1.1

ng/l

239.7

843.2

0.77

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

147

2.76

12.84

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

334

2708

0.65

12.79

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

333

2701

0.65

12.78

1.3

1.5

—

(3000991) Gas panel - Venous blood

1318

5637

1.26

12.75

7.2

9.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

605

2312

1.41

12.72

2.1

2.7

ug/l

302.4

653.8

3.50

557

2174

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.47

12.57

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

141

368

2.05

12.55

1.2

1.4

u/ml

0.7

0.8

0.10

170

(3043238) Trisomy 21 risk [Likelihood] in Fetus

343

2753

0.66

12.51

1.4

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1026

4271

1.29

12.32

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1399

6055

1.25

12.21

3.5

4.3

ug/l

20.1

24.5

0.27

1114

4968

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

233

727

1.71

12.11

1.1

g/l

1.5

0.30

207

667

(4211845)

108

257

2.24

12.07

4.5

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

466

1716

1.46

12.00

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

169

2.56

11.93

1.2

g/l

0.3

0.63

136

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

356

1241

1.54

11.92

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

104

246

2.26

11.79

1.4

1.2

nmol/l

130.0

134.0

0.39

104

246

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

213

2.36

11.71

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

339

2673

0.67

11.34

1.4

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

158

2.57

11.29

1.6

2.2

ug/l

0.7

0.9

0.68

151

(40768800) Prostate Pathology biopsy report

365

1296

1.51

11.27

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

8.20

11.02

1.1

4.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

306

1051

1.56

10.98

1.6

1.5

nmol/l

0.3

0.4

1.95

254

879

(4146454)

178

530

1.80

10.89

2.6

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

289

985

1.57

10.73

1.2

u/l

45.7

40.7

0.16

252

842

(3006462) Nitrate [Presence] in Urine

233

2.22

10.66

4.7

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

181

547

1.77

10.56

1.3

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

235

2.20

10.46

1.7

1.8

nmol/l

3.8

12.9

0.46

205

(40768446) Kidney Pathology biopsy report

511

0.30

10.41

1.3

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

162

2.47

10.38

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

392

1447

1.45

10.04

2.8

3.1

—

(3037756) Immunofixation for Serum or Plasma

347

1251

1.49

10.01

1.5

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.72

9.91

1.4

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

306

1080

1.52

9.78

3.0

3.6

1.3

1.6

0.66

224

846

(3006270) Folate [Moles/volume] in Blood

173

529

1.75

9.75

1.2

1.1

nmol/l

386.9

350.8

1.22

146

415

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

155

2.44

9.65

1.2

108.6

116.6

1.45

140

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

806

3364

1.29

9.54

2.8

5.6

mmol/l

24.2

23.9

2.40

739

3021

(3035933) Granulocytes/100 leukocytes in Blood

124

2.62

9.53

1.9

3.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

137

395

1.85

9.35

1.3

1.2

umol/l

5.4

6.0

0.90

128

371

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

304

1086

1.50

9.21

1.6

1.4

pmol/l

112.5

114.6

0.02

293

1050

(3019060) Gas panel - Arterial blood

992

4272

1.25

9.09

3.6

5.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

476

1854

1.38

9.07

2.5

3.3

mmol/l

25.0

24.4

1.99

400

1679

(3037556) Urate [Mass/volume] in Serum or Plasma

2.80

8.99

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3115

14838

1.14

8.97

1.6

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

143

424

1.80

8.96

1.1

mg/l

300.5

294.7

0.27

128

383

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

109

296

1.97

8.88

1.2

1.4

85.3

64.4

1.76

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

107

2.69

8.87

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

139

2.46

8.82

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

109

297

1.96

8.80

1.1

1.0

u/ml

0.4

0.8

0.54

(3024471) HLA-A [Type]

399

0.28

8.75

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.81

8.69

1.7

1.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

3.71

8.57

1.0

1.1

ug/l

79.1

94.3

1.09

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.45

8.53

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

253

2.02

8.50

1.6

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

142

2.40

8.46

1.2

1.3

nmol/l

133.0

127.4

0.09

101

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

110

2.62

8.45

1.1

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

213

717

1.59

8.44

1.4

pmol/l

292.1

352.8

0.67

172

567

(3019420) Tryptase [Mass/volume] in Serum or Plasma

258

2.01

8.38

1.5

1.6

ug/l

6.7

9.1

0.64

239

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

267

948

1.51

8.37

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

101

273

1.97

8.36

1.2

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

101

273

1.97

8.36

1.2

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

419

1623

1.38

8.30

2.4

3.3

kpa

8.1

8.2

0.40

385

1534

(3044927) Protein electrophoresis panel - Urine

167

531

1.68

8.28

1.1

1.2

—

(3020891) Body temperature

585

2388

1.31

8.22

3.9

5.5

—

(3011985) Renin [Units/volume] in Plasma

226

777

1.55

8.21

1.5

1.6

mu/l

71.0

52.9

0.52

199

695

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.57

8.20

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

148

458

1.73

8.09

2.0

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

167

536

1.66

8.01

1.6

1.4

promille

1.5

1.1

2.33

134

415

(3012544) pH of Venous blood

1520

6923

1.18

7.91

3.0

4.9

7.4

0.67

(3006184) Hemoglobin [Mass/volume] in Capillary blood

421

1646

1.37

7.90

2.0

2.5

g/l

131.7

128.5

1.40

280

1311

(3028433) Virus identified in Specimen by Culture

189

2.15

7.82

1.2

—

(3024932) HLA-DR beta [Type]

389

0.31

7.75

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

267

1.94

7.67

2.7

2.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

137

422

1.73

7.64

1.6

1.9

mg/l

3.8

4.9

1.87

127

401

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

126

2.41

7.64

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.69

7.63

2.9

2.4

mmol/l

7.6

7.8

0.11

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

325

1.84

7.59

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

520

2114

1.32

7.56

2.5

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

135

417

1.73

7.47

2.2

2.7

e6/l

499.4

500.6

0.01

118

346

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

128

2.37

7.40

1.1

—

(3002032) Base excess in Venous blood by calculation

1470

6716

1.18

7.38

3.1

4.9

mmol/l

1.9

1.7

1.17

1167

5441

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

100

283

1.89

7.32

2.3

2.7

au/ml

204.2

99.6

0.57

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

174

579

1.61

7.30

3.7

4.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

2.51

7.15

1.0

1.2

mg/l

209.6

78.5

0.40

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1473

6751

1.17

7.13

3.1

4.9

kpa

5.8

0.77

1421

6521

(3018405) Lactate [Moles/volume] in Arterial blood

522

2142

1.31

7.13

3.0

4.5

mmol/l

1.4

1.5

1.49

515

2088

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

274

1013

1.45

7.11

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

107

313

1.82

7.10

1.1

iu/ml

3.9

5.8

—

(3042631) Mycobacterium sp identified in Specimen

235

843

1.49

7.10

2.9

2.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

132

1145

0.61

7.07

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

130

404

1.72

7.07

2.2

2.8

e9/l

0.2

1.04

116

344

(3008295) Osmolality of Serum or Plasma

183

622

1.57

7.05

1.4

1.5

mosm/kgh2o

279.8

283.9

1.62

135

493

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

122

373

1.75

7.02

1.3

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

109

323

1.80

6.95

2.6

3.3

mg/l

7.1

8.5

1.50

261

(3020874) Milk IgE Ab [Units/volume] in Serum

117

355

1.76

6.91

1.1

1.0

u/ml

7.2

1.6

0.40

104

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

186

638

1.56

6.90

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

126

2.33

6.88

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.77

6.83

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

247

903

1.46

6.81

2.9

2.2

13.2

13.1

1.27

247

885

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

120

2.35

6.80

1.3

1.5

ug/l

8.8

9.9

0.78

120

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

495

3378

0.77

6.79

1.3

1.5

—

(4015189)

107

2.44

6.78

2.2

2.4

—

(1616796) Gas panel - Central venous blood

427

1717

1.33

6.75

3.2

4.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

123

382

1.72

6.72

1.3

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

335

1.77

6.69

1.1

1.0

u/ml

3.1

2.6

0.07

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

288

1088

1.42

6.68

1.4

1.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

108

2.42

6.66

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

108

2.42

6.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

108

2.42

6.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

108

2.42

6.66

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

144

1206

0.63

6.64

2.4

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

144

469

1.64

6.62

4.0

4.8

u/ml

96.1

99.5

0.02

151

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

648

2763

1.26

6.57

1.8

2.0

ug/l

1.6

2.3

1.18

551

2459

(3020491) Glucose [Moles/volume] in Blood

143

466

1.64

6.57

1.7

mmol/l

6.6

0.03

338

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

539

0.46

6.53

2.3

2.6

nmol/l

122.7

155.0

2.09

464

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

839

3684

1.22

6.51

8.2

10.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

241

887

1.45

6.45

6.6

6.9

mg/l

11.2

11.7

0.78

223

817

(3011412) CD3 cells [#/volume] in Blood

178

615

1.55

6.44

2.3

2.5

e9/l

1.2

1.0

1.40

389

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

282

1.82

6.34

1.3

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

1201

5470

1.18

6.29

2.6

3.8

kpa

4.5

4.7

1.64

1151

5256

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

2.19

6.23

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.38

6.22

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

130

420

1.65

6.20

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

179

2.03

6.16

2.0

3.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1447

6705

1.16

6.11

4.6

10.7

mmol/l

9.8

10.9

6.29

1360

6394

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

441

1814

1.30

5.99

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

368

1478

1.33

5.92

1.5

1.6

—

(40768793) Breast Pathology biopsy report

255

965

1.41

5.92

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

314

0.34

5.92

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

173

607

1.52

5.88

1.4

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

165

573

1.54

5.88

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.22

5.83

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

475

3191

0.79

5.78

1.3

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

475

3189

0.79

5.75

1.3

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

137

2.14

5.75

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

927

4162

1.20

5.75

5.1

7.5

mmol/l

24.5

24.4

0.45

856

3880

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

642

2779

1.24

5.75

1.3

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

438

1814

1.29

5.67

3.1

4.9

mmol/l

3.8

3.9

2.22

407

1680

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

473

3169

0.79

5.64

1.3

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.36

5.62

1.1

1.2

—

(4133840)

160

2.03

5.62

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.81

5.61

1.3

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

162

567

1.53

5.59

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

601

2592

1.24

5.58

1.3

miu/ml

190.1

237.9

2.73

275

1157

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

476

3181

0.79

5.56

1.3

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

237

897

1.41

5.53

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

332

1.69

5.47

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

289

1135

1.36

5.42

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

111

358

1.65

5.39

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

227

1.83

5.37

2.0

2.1

umol/l

2.0

1.9

0.40

215

(3013293) Extractable nuclear Ab [Presence] in Serum

2.71

5.29

2.0

—

(3020650) Glucose [Presence] in Urine

146

2.04

5.26

1.6

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

293

1160

1.35

5.24

1.8

5.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

164

585

1.50

5.22

3.0

3.3

nmol/l

7.3

7.0

0.03

159

568

(3001556) Androgen free Index in Serum or Plasma

2.43

5.17

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

2.06

5.10

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

193

715

1.44

5.10

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

370

1524

1.30

5.05

1.4

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

135

467

1.54

4.97

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

251

979

1.37

4.96

1.6

2.0

titre

7885.7

2640.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

285

1.70

4.95

1.6

umol/l

19.5

24.2

0.85

270

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

131

451

1.55

4.92

2.0

2.8

e6/l

802.9

596.2

2.00

168

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

377

1563

1.29

4.91

1.4

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

184

1.88

4.90

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

155

555

1.49

4.88

1.4

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.33

4.86

1.6

1.8

ug/l

0.3

0.5

1.79

(3041806) Other cells [#/volume] in Blood by Manual count

636

0.58

4.86

1.8

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

117

394

1.58

4.84

1.7

u/ml

37.8

29.0

0.69

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

133

2.04

4.82

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

308

1.66

4.80

3.1

3.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

156

562

1.48

4.77

1.4

1.3

nmol/l

1.6

1.4

1.47

140

514

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

108

358

1.61

4.77

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

322

1.64

4.71

3.9

3.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.20

4.70

1.6

mg/l

0.9

4.1

1.47

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

1.90

4.69

1.2

12.8

16.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

161

1.92

4.65

1.1

1.3

—

(3051339) Copper [Moles/volume] in Blood

3.87

4.61

1.3

1.1

umol/l

16.6

16.5

0.05

(3010838) Calcium [Moles/time] in 24 hour Urine

243

1.73

4.61

1.6

mmol/24h

9.1

4.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

129

2.02

4.54

1.0

1.1

mg/g

6.7

5.8

0.44

123

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

246

972

1.35

4.52

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

338

1398

1.29

4.52

2.4

3.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

143

513

1.49

4.49

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

448

0.52

4.43

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

113

387

1.56

4.39

2.2

2.7

e9/l

0.2

0.4

0.65

108

377

(1175426) CD3 cells/100 lymphocytes in Blood

140

503

1.49

4.38

2.3

2.0

73.0

72.5

0.17

133

484

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

1.4

3.2

0.59

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

1.7

3.1

0.43

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

0.6

0.7

0.11

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.13

4.36

1.1

nmol/l

7.9

18.8

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

1.6

2.6

0.33

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

0.4

3.0

1.33

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

2.4

2.9

0.16

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

3.3

2.7

0.09

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

1.4

3.0

0.87

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.13

4.36

1.5

1.6

mg/l

2.5

3.5

0.34

(3047189) Immunofixation for 24 hour Urine

240

1.71

4.32

1.9

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

437

0.52

4.31

1.1

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

217

1.74

4.26

1.4

pmol/l

14.5

15.0

0.37

188

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

106

361

1.57

4.24

1.8

u/field

2.7

3.7

0.40

267

(3042111) Morphology [Interpretation] in Bone marrow Narrative

262

1060

1.32

4.15

1.4

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

321

1.59

4.15

1.1

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

188

1.79

4.11

1.2

1.0

u/ml

5.9

14.2

1.32

(3003181) Sodium [Moles/volume] in Urine

270

1100

1.31

4.08

1.4

mmol/l

65.0

61.5

0.60

217

863

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.61

4.06

1.4

1.6

umol/l

39.9

46.6

0.79

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

270

1854

0.77

4.06

2.6

7.3

iu/ml

792.7

748.3

0.05

328

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.13

4.04

2.0

2.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

332

1.57

4.03

1.4

1.3

titre

112.9

614.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

107

371

1.54

3.98

1.2

g/l

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

527

1.45

3.98

1.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

190

1.77

3.98

2.0

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

292

1207

1.29

3.98

3.0

3.4

u/ml

510.5

1087.2

0.47

272

1090

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

218

1.71

3.97

2.9

2.4

—

(3036603) Volume of Urine

116

410

1.51

3.96

1.6

1985.6

2015.9

0.05

142

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

103

355

1.55

3.94

1.5

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

293

1214

1.29

3.92

1.1

—

(3000330) Specific gravity of Urine by Test strip

798

3663

1.17

3.92

3.4

3.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.23

3.89

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

323

1.57

3.86

4.4

8.2

u/ml

1297.1

8917.5

0.57

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

278

1149

1.29

3.81

1.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

233

1.67

3.81

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

211

840

1.34

3.77

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

158

602

1.40

3.70

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

135

500

1.44

3.69

2.3

2.0

13.5

15.2

0.70

221

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

231

936

1.32

3.67

1.2

—

(3023419) Bacteria identified in Sputum by Culture

196

776

1.35

3.64

2.6

2.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

102

358

1.52

3.63

1.5

1.6

—

(3004775) Volume in Urine collected for unspecified duration

768

0.67

3.62

1.8

2.6

601.1

673.0

1.02

549

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

225

911

1.32

3.60

1.4

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

658

2999

1.17

3.57

2.0

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.16

3.55

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

895

1.32

3.54

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

340

1456

1.25

3.52

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.17

3.50

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

170

663

1.37

3.49

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.18

3.48

1.0

1.6

—

(3047181) Lactate [Moles/volume] in Blood

487

2168

1.20

3.47

4.5

6.3

mmol/l

1.3

0.40

417

1936

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.26

3.45

2.4

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

355

1535

1.24

3.39

3.7

2.7

mg/l

24.8

31.2

2.27

214

1033

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.99

3.35

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.16

3.35

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.03

3.34

1.4

1.7

—

(4198724)

120

444

1.44

3.34

2.2

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

195

783

1.33

3.34

1.4

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

301

1.54

3.34

1.8

2.1

ug/min

42.9

138.9

2.02

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

122

1.88

3.34

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.49

3.32

1.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

112

411

1.45

3.26

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.27

3.25

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

3.24

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.74

3.22

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

948

0.72

3.21

1.4

1.6

—

(3024928) Oxygen saturation in Venous blood

336

1455

1.23

3.19

2.1

4.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

414

1.44

3.16

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

125

472

1.41

3.14

2.4

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

156

612

1.36

3.14

2.4

3.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

100

362

1.47

3.14

1.1

1.2

u/l

74.5

99.7

2.04

331

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

388

0.58

3.13

1.9

2.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.99

3.12

2.5

4.8

u/l

134.7

73.7

0.26

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

164

651

1.34

3.07

3.8

3.3

u/ml

32.1

37.2

0.28

159

628

(3001218) Citrate [Mass/time] in 24 hour Urine

7.46

3.03

1.3

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

208

1416

0.78

3.03

1.6

3.5

u/ml

4080.2

9417.6

0.32

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

685

3178

1.15

3.01

2.3

3.4

0.7

0.60

660

3081

(4034850)

453

2036

1.19

2.96

12.1

9.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

373

0.58

2.91

3.4

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

373

0.58

2.91

6.7

5.9

—

(3036180) Methadone [Presence] in Urine

4.79

2.90

2.9

4.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

700

3262

1.15

2.90

2.3

3.4

1.3

1.2

0.50

695

3243

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.42

2.88

1.2

1.1

umol/24h

1.7

1.6

0.24

(3043410) Blood group antigens tested for on Red Blood Cells

181

1.65

2.88

1.4

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.93

2.82

1.1

umol/24h

0.7

0.6

0.48

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

353

1.45

2.82

1.1

1.2

u/l

18.0

25.3

1.41

321

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

194

0.44

2.81

6.6

10.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

245

1041

1.26

2.80

1.3

u/ml

4.6

4.2

0.15

108

506

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.45

2.78

1.0

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

6.21

2.76

1.3

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

2.76

0.0

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.25

2.75

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

213

1.58

2.73

1.7

2.6

ug/l

146.3

514.6

0.55

194

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.36

2.71

1.1

—

(3004451) EKG impression Narrative

321

1.46

2.71

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.19

2.69

1.0

u/ml

0.0

0.2

0.93

(3028717) Thiamine [Mass/volume] in Blood

2.19

2.69

1.2

1.1

—

(3025315) Body weight

101

0.32

2.68

1.5

5.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

109

1.81

2.63

1.1

1.2

pmol/l

254.2

467.1

0.75

(40765096) Chromosome analysis panel by Banding

149

1.68

2.62

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.73

2.61

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.73

2.61

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

2.57

0.0

1.7

—

(40768795) Lymph node Pathology biopsy report

134

532

1.34

2.57

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

150

607

1.32

2.53

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

171

0.44

2.53

6.9

11.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

108

0.34

2.53

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

163

1.63

2.53

1.7

2.1

umol/l

13.2

17.4

2.10

163

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.96

2.53

1.1

1.0

u/ml

0.3

0.0

0.43

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.93

2.51

2.4

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.93

2.51

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

144

581

1.32

2.49

1.9

2.0

u/field

1.9

2.1

0.18

220

(3030313) Adrenal Ab [Titer] in Serum

2.19

2.49

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

130

518

1.34

2.45

1.2

1.4

titre

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

293

1.46

2.45

1.2

u/ml

24.6

9.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.91

2.43

1.2

1.1

u/ml

26.0

4.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

145

0.40

2.42

1.2

2.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

289

1275

1.21

2.39

1.7

2.3

umol/l

6.1

6.3

0.09

199

957

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

286

1.45

2.38

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

286

1.45

2.38

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

286

1.45

2.38

1.4

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

162

1.61

2.37

2.3

2.1

e6/l

174.6

603.1

0.43

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

154

634

1.30

2.33

1.1

1.2

u/l

54.9

68.9

2.26

109

450

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

141

970

0.77

2.33

1.4

1.7

mmol/l

8.0

7.3

2.33

509

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

489

2262

1.15

2.32

3.2

3.4

u/ml

677.7

1215.3

0.52

418

1955

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

130

1.68

2.32

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

106

414

1.36

2.29

1.3

1.2

mmol/l

39.1

33.7

1.30

365

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.06

2.26

1.1

—

(4268621)

171

718

1.27

2.24

2.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

299

1.43

2.24

1.9

2.1

umol/l

11.6

24.1

1.18

(3045716) Anion gap in Serum or Plasma

308

1.42

2.23

1.9

2.2

mmol/l

10.2

9.0

1.27

226

(21494815) CD4 cells/100 lymphocytes in Specimen

147

606

1.29

2.22

2.0

2.2

45.5

40.2

0.72

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.32

2.22

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

163

682

1.27

2.20

1.2

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

287

1.43

2.19

1.4

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

377

1.37

2.18

2.7

3.0

u/ml

26.1

54.2

1.94

368

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.02

2.17

1.0

u/ml

0.6

0.1

0.34

(3004119) Hemoglobin [Mass/volume] in Venous blood

911

4403

1.11

2.15

2.8

4.0

g/l

131.7

127.2

7.35

881

4312

(3044242) Glucose [Moles/volume] in Arterial blood

324

1.40

2.15

1.6

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

117

470

1.33

2.14

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

117

470

1.33

2.14

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

117

470

1.33

2.14

1.4

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.94

2.13

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.03

2.12

1.0

u/ml

0.3

0.5

0.11

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.87

2.10

1.0

u/ml

0.6

0.2

0.45

(3001186) Copper [Moles/volume] in Serum or Plasma

130

1.64

2.10

1.6

1.3

umol/l

16.4

16.0

0.15

113

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

126

1.65

2.09

1.1

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

287

1285

1.19

2.08

1.8

2.2

titre

3.6

9.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

477

1.32

2.08

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

102

1.72

2.07

1.0

1.1

u/ml

0.3

3.7

1.79

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

300

1.40

2.05

2.0

2.5

umol/l

49.0

53.5

0.87

251

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

225

1.47

2.04

1.5

2.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

212

1.48

2.04

1.1

93.6

80.3

1.66

114

(3016750) Collection duration of Urine

552

0.72

2.03

1.7

2.6

min

467.8

503.5

1.51

449

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.47

2.00

1.4

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

266

1.42

2.00

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.28

1.97

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

245

1087

1.20

1.97

1.3

u/ml

3.0

4.7

0.82

400

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

111

449

1.32

1.96

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

267

1.42

1.96

2.2

1.9

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.78

1.95

1.5

1.6

ug/l

95.0

108.3

0.31

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.96

1.95

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.74

1.95

1.2

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

224

1.45

1.92

1.1

1.2

103.9

100.7

0.26

212

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.97

1.89

1.0

u/ml

0.0

2.4

0.60

(3001729) Color of Synovial fluid

2.22

1.87

2.0

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

122

1.62

1.87

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

173

1.51

1.86

2.2

1.8

u/l

31.5

33.5

0.05

157

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

217

1.45

1.85

1.1

95.7

82.6

2.60

115

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

100

403

1.32

1.84

1.3

1.4

mmol/l

5.6

5.4

1.18

385

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

221

979

1.20

1.84

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.99

1.83

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

222

1.44

1.83

1.5

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

222

1.44

1.83

1.5

2.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

200

1.47

1.83

1.3

1.2

ug/l

523.5

40.8

0.49

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.90

1.79

1.0

u/ml

0.1

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

447

1.30

1.78

2.1

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

109

447

1.30

1.78

1.0

1.1

—

(3036489) Thrombin time

554

2638

1.12

1.78

2.0

2.5

21.1

21.5

1.12

483

2351

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

206

1.45

1.77

2.7

2.9

umol/l

27.7

29.2

0.39

149

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

217

965

1.20

1.75

1.1

1.2

116.4

110.5

1.81

198

890

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.08

1.73

1.1

1.0

u/ml

15.9

12.8

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.08

1.73

1.1

1.0

u/ml

45.8

13.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

1.51

1.73

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.37

1.72

1.3

1.4

umol/24h

351.1

344.5

0.03

(3011648) Oxygen content in Venous blood

126

530

1.27

1.71

1.7

2.8

11.1

0.00

126

530

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

262

1188

1.18

1.70

1.1

iu/ml

135.1

1955.2

0.98

255

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

207

0.59

1.70

3.3

5.7

65.3

70.8

0.37

170

(3016135) IgD [Mass/volume] in Serum

2.84

1.69

1.4

1.1

mg/l

98.7

121.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.11

1.67

1.4

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

405

1.30

1.67

1.1

1.2

ratio

1.1

0.54

151

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

183

1.46

1.64

1.1

1.0

—

(4038314)

1.73

1.64

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.13

1.61

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

175

1.46

1.61

1.1

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

1.61

0.0

1.1

—

(21494434) Karyotype in Bone marrow

127

540

1.25

1.60

1.2

—

(40768441) Liver Pathology biopsy report

106

441

1.28

1.59

1.2

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

1.58

0.0

4.4

—

(3022689) Creatine [Moles/volume] in Urine

176

1.45

1.57

1.6

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.98

1.56

1.4

1.1

u/l

16.8

7.0

1.09

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

303

1.34

1.55

6.5

6.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2052

11481

0.95

1.55

1.7

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.87

1.54

1.4

1.2

4.4

3.2

—

(3049242) von Willebrand panel - Platelet poor plasma

2.66

1.54

1.6

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

1.54

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.67

1.52

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.81

1.51

2.1

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.78

1.51

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

2.52

1.49

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

321

1497

1.14

1.49

2.3

2.6

umol/l

35.8

32.1

0.62

265

1265

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.63

1.47

1.1

1.3

nmol/l

0.3

0.2

0.08

(3051101) Glucose [Moles/volume] in Cord blood

172

0.59

1.47

6.6

5.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

117

0.50

1.47

8.2

7.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

357

1682

1.13

1.43

1.1

1.3

—

(4306422)

221

1006

1.17

1.43

1.2

—

(3017569) Oxygen content in Arterial blood

313

1.31

1.40

1.9

2.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.90

1.40

1.3

2.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

309

1.31

1.39

1.0

ng/l

273.8

334.7

1.39

219

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

363

1716

1.13

1.39

2.1

2.7

ug/min

143.2

110.5

0.44

201

1096

(3006567) Chloride [Moles/time] in 24 hour Urine

3.33

1.38

2.0

1.3

—

(3041184) Isoniazid [Presence] in Urine

3.33

1.38

1.6

2.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

114

0.51

1.37

2.2

2.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.04

1.37

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.04

1.37

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.28

1.36

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

116

1.52

1.35

1.2

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

136

596

1.22

1.35

1.8

1.9

g/24h

1.5

1.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

638

0.80

1.33

8.7

13.5

mmol/l

0.6

0.7

4.23

594

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

121

525

1.23

1.32

1.2

1.3

titre

186.4

193.4

0.03

(3012441) Differential panel - Pleural fluid

180

814

1.18

1.29

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.63

1.28

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

290

1.30

1.28

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.78

1.25

1.1

iu/ml

6.8

13.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.59

1.25

2.0

2.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.54

1.24

1.8

2.8

umol/l

42.1

41.4

0.04

(44806071)

1.60

1.24

1.1

—

(3012565) Volume of 24 hour Urine

334

1.28

1.23

2.6

2.3

2268.9

1794.9

2.38

295

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

203

933

1.16

1.21

2.4

2.9

u/ml

86.4

1318.5

0.90

191

856

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

1.19

1.2

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

219

1.34

1.19

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

174

0.64

1.18

1.3

1.4

g/l

24.3

27.6

0.38

146

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

313

1.28

1.17

1.0

ng/l

39.3

44.5

0.64

219

(3033942) Copper [Moles/time] in 24 hour Urine

2.02

1.15

1.1

1.2

umol/24h

0.2

1.8

—

(40768806) Pleura Pathology biopsy report

178

815

1.16

1.13

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.57

1.13

1.1

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

337

1611

1.12

1.1

1.4

u/ml

243.3

266.8

0.83

200

1103

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

254

1.30

1.12

2.3

2.2

175.1

179.2

0.11

245

(3048879) Bone marrow aspiration report

144

1.41

1.12

1.4

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

208

1.33

1.11

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

278

1.28

1.11

1.1

91.6

94.0

0.26

229

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.33

1.11

1.1

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

209

0.69

1.10

1.7

1.4

g/l

15.0

14.5

0.11

170

(3012494) Peanut IgE Ab [Units/volume] in Serum

181

1.35

1.09

1.1

u/ml

5.8

59.9

0.47

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

374

1.24

1.09

1.6

u/l

8.0

6.9

0.18

189

(3036782) Glucose [Moles/volume] in Pleural fluid

159

725

1.17

1.08

1.4

mmol/l

6.3

6.4

0.40

146

679

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

313

1.26

1.06

1.0

ng/l

803.0

704.6

0.87

213

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

608

0.82

1.06

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

438

1.22

1.06

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

342

1.25

1.06

1.6

1.5

nmol/l

1.2

0.05

277

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.19

1.05

1.6

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.00

1.04

1.6

1.4

nmol/l

389.6

454.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

353

0.77

1.04

2.8

3.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

1.03

0.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.61

1.03

1.6

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.50

1.00

1.3

1.2

u/l

16.3

20.5

0.59

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.51

0.98

3.3

2.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

112

1.43

0.98

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

111

496

1.19

0.98

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

218

1.29

0.97

1.2

—

(3007463) Buprenorphine [Presence] in Urine

1.84

0.97

9.2

3.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.62

0.95

1.3

1.2

ug/l

143.4

110.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

154

1.35

0.94

2.4

1.2

97.7

107.5

1.02

147

(3040151) Glucose [Moles/volume] in Capillary blood

189

886

1.14

0.92

5.2

17.7

mmol/l

7.3

7.4

0.17

156

730

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.90

0.92

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.90

0.92

1.1

1.7

pmol/l

1.5

77.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.83

0.91

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

732

1.15

0.91

1.1

1.2

97.3

91.1

2.14

149

695

(3000012) Reticulocyte production index

398

1.20

0.90

1.8

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

216

1.28

0.90

1.7

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

168

0.70

0.88

3.0

2.9

—

(3044007) Cell count panel - Peritoneal fluid

205

0.73

0.87

2.0

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

375

2171

0.92

0.87

4.6

3.8

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.69

0.86

1.8

mmol/l

21.8

21.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.77

0.84

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.46

0.84

3.5

2.5

u/field

0.5

0.01

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

202

0.74

0.81

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

178

840

1.13

0.81

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.62

0.81

1.1

1.3

—

(3019977) pH of Arterial blood

389

1.19

0.80

2.3

2.6

7.4

0.01

123

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.42

0.80

6.8

mmol/l

0.3

0.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

196

933

1.12

0.78

1.5

e6/l

1705.8

1791.6

0.10

131

668

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

154

723

1.13

0.77

1.3

u/l

284.4

562.1

1.75

144

683

(3009466) Valproate [Moles/volume] in Serum or Plasma

220

1297

0.90

0.77

4.4

5.8

umol/l

339.8

381.8

4.73

195

1157

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

421

2081

1.08

0.77

2.5

3.0

177.8

190.4

2.07

397

1990

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.57

0.77

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

178

844

1.12

0.77

1.5

1.4

e6/l

77370.4

42653.1

0.42

101

485

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

121

559

1.15

0.76

1.4

umol/l

11.7

13.2

1.86

115

528

(3022493) Free Hemoglobin [Mass/volume] in Plasma

395

0.82

0.76

7.3

8.5

mg/l

62.7

995.4

0.84

298

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

100

0.64

0.75

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

265

0.78

0.75

2.2

2.1

e6/l

571.0

2905.4

0.54

189

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.61

0.74

1.2

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

120

556

1.15

0.74

1.3

u/l

12.1

15.4

0.94

110

503

(3017704) Immunofixation for Urine

354

1.19

0.73

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

240

0.78

0.73

2.2

1.9

e6/l

8400.0

13011.5

0.32

133

(3033799) Differential panel - Peritoneal fluid

222

0.77

0.73

1.5

2.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.64

0.73

1.0

1.3

u/field

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

148

1.30

0.71

1.2

67.7

80.8

0.89

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.45

0.70

5.3

7.8

umol/l

0.3

0.12

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.52

0.70

1.2

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

145

685

1.13

0.69

3.3

3.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.69

0.68

1.3

1.0

nmol/l

209.1

214.9

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.69

0.68

1.1

1.0

mmol/l

8.0

8.6

—

(3029612) Listeria sp Ab [Titer] in Serum

1.90

0.68

1.4

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

383

2186

0.93

0.67

2.2

4.1

mg/l

1.4

1.7

9.66

343

2022

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

601

3026

1.06

0.67

4.0

5.2

1.7

1.6

0.28

563

2862

(3038515) Glucose [Moles/volume] in Venous blood

307

1765

0.92

0.66

3.2

3.3

mmol/l

7.8

7.9

0.23

298

1741

(3027456) Digoxin [Moles/volume] in Serum or Plasma

270

1559

0.92

0.65

3.0

3.1

nmol/l

0.8

0.45

205

1197

(3044009) aPTT.lupus sensitive (LA screen)

1.47

0.65

1.1

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.77

0.64

1.0

—

(3045788) Cell count panel - Pleural fluid

153

730

1.12

0.63

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.48

0.63

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

1.27

0.61

1.2

70.6

86.5

1.49

(4212803)

1.49

0.61

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.58

0.61

7.4

10.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

244

1.20

0.60

1.3

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.50

0.59

1.2

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

333

1.17

0.59

1.3

1.4

70.8

73.2

0.67

313

(3008116) Ketones [Moles/volume] in Urine by Test strip

149

1.25

0.56

2.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.60

0.54

1.3

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

326

1.16

0.54

1.3

1.4

mu/l

361.6

747.4

2.59

306

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

351

1.15

0.54

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

351

1.15

0.54

1.4

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

290

1653

0.93

0.53

1.2

1.7

u/ml

110.1

112.5

0.19

377

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

395

0.86

0.52

1.1

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

589

2995

1.05

0.50

4.1

5.2

0.9

0.28

550

2836

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

448

2262

1.06

0.50

2.0

2.7

91.3

90.8

0.18

414

2141

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

568

0.89

0.50

1.4

2.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.35

0.50

2.7

2.3

mmol/l

0.5

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

294

1467

1.07

0.49

1.5

2.8

nmol/l

0.9

0.8

0.87

248

1222

(3034426) Prothrombin time (PT)

245

1.17

0.49

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

321

1610

1.06

0.47

1.9

1.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

105

1.27

0.46

1.1

3.3

mmol/l

5.9

7.4

—

(3039000) Anion gap in Blood

309

1549

1.06

0.46

5.4

7.3

mmol/l

11.2

11.3

0.20

271

1413

(3008536) Aspergillus sp Ab [Presence] in Serum

139

1.23

0.46

1.7

2.9

—

(3018572) Chloride [Moles/volume] in Blood

309

1550

1.06

0.45

5.4

7.3

mmol/l

105.4

105.0

1.02

271

1414

(3008037) Lactate [Moles/volume] in Venous blood

328

1848

0.94

0.45

3.1

3.2

mmol/l

1.6

1.7

0.93

318

1817

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

120

1.24

0.45

2.0

2.1

ng/l

65.9

82.4

0.59

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.30

0.44

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.66

0.44

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

184

1055

0.93

0.43

2.3

2.4

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.42

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

104

501

1.11

0.42

1.5

1.9

—

(44806118)

158

777

1.08

0.41

1.3

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

146

1.20

0.41

1.5

2.0

mmol/l

1.2

0.99

140

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.31

0.41

1.1

1.0

mg/l

35.6

49.5

—

(44790048)

158

778

1.08

0.40

1.3

1.7

—

(44790049)

158

778

1.08

0.40

1.3

1.7

—

(44790047)

158

778

1.08

0.40

1.3

1.7

—

(3034614) HLA Ag [Interpretation]

1.48

0.40

1.4

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.39

0.40

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.74

0.39

1.1

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

103

602

0.91

0.39

1.4

nmol/l

28.5

34.8

1.81

571

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.44

0.39

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.44

0.39

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

139

0.80

0.39

1.1

1.3

mmol/l

1.9

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.38

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

179

0.83

0.38

1.8

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

213

1206

0.94

0.37

1.2

—

(4281824)

105

611

0.91

0.37

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

285

1439

1.06

0.37

1.3

1.2

ug/l

3.3

4.0

1.00

269

1345

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.73

0.37

1.0

1.2

—

(40757373) Influenza virus identified in Isolate

195

0.85

0.36

1.3

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

420

1.10

0.36

2.6

2.8

40.1

38.7

0.24

153

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

144

1.18

0.35

1.2

1.6

ng/l

2696.9

105.0

0.46

100

(3042951) Complement C1q Ab [Units/volume] in Serum

1.33

0.34

1.0

1.4

—

28.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

644

3323

1.03

0.32

3.7

4.5

47.2

47.7

0.19

635

3288

(3023383) Lactate [Moles/volume] in Pleural fluid

236

1.13

0.31

1.2

1.4

mmol/l

3.2

3.5

0.31

219

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

157

784

1.07

0.31

1.3

1.4

mmol/l

12.3

11.4

0.49

151

(3020393) Adenovirus Ag [Presence] in Stool

1.29

0.31

1.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.33

0.30

1.8

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

364

1.10

0.30

7.7

15.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.30

0.29

1.1

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

1.25

0.28

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

446

0.92

0.27

1.1

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.33

0.27

1.0

1.1

u/ml

2.6

15.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

305

1.10

0.27

1.1

1.2

u/l

35.1

28.0

0.20

227

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.81

0.27

1.1

1.3

u/l

23.9

83.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.29

0.27

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

702

3645

1.03

0.26

3.2

4.1

mmol/l

25.1

24.9

0.56

673

3533

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

306

1.10

0.26

1.1

1.2

u/l

95.7

89.4

0.13

236

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

1.11

0.25

2.5

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.69

0.25

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

216

1100

1.05

0.24

1.2

1.4

mmol/l

7.3

6.9

0.92

167

725

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

130

1.15

0.23

1.6

1.5

7.7

12.9

0.64

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.22

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.22

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.22

0.0

2.7

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.22

0.0

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

121

1.14

0.21

2.4

1.9

ng/l

147.2

164.3

0.19

121

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

121

1.14

0.21

1.0

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.28

0.21

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

208

1064

1.04

0.20

1.5

g/l

31.7

30.7

0.52

182

938

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

280

1.08

0.20

1.5

61.6

66.0

0.40

225

(3019174) dRVVT (LA screen)

1.21

0.19

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

122

617

1.05

0.19

3.2

mg/l

30.1

70.7

1.84

446

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.18

0.19

1.4

1.2

46.2

40.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.18

0.19

2.8

2.6

—

(3013762) Body weight Measured

1.12

0.16

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.12

0.16

1.3

1.1

—

(3014891) Appearance of Pleural fluid

126

0.89

0.16

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

367

1.06

0.15

1.1

miu/ml

1737.0

1515.8

0.80

367

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.21

0.14

1.3

2.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.79

0.14

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

108

0.89

0.14

1.1

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

211

0.93

0.12

1.1

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.17

0.12

2.4

5.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

134

0.91

0.11

11.3

6.1

—

(44806420)

236

1.06

0.11

2.6

2.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.12

0.11

1.3

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

522

2740

1.01

0.11

3.1

3.4

u/ml

0.3

0.23

291

1544

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

133

0.92

0.10

1.3

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.06

0.09

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

248

1.05

0.09

1.2

1.7

—

(3000285) Sodium [Moles/volume] in Blood

1.10

0.09

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.87

0.09

6.2

4.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.16

0.09

1.2

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

432

1.04

0.09

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

441

2317

1.01

0.09

2.2

2.9

g/l

3.7

3.6

0.37

414

2210

(3022475) Manganese [Moles/volume] in Blood

1.04

0.07

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.89

0.07

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.13

0.07

1.0

—

(3051651) Icteric interference index of Serum or Plasma

432

0.97

0.06

3.7

4.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.93

0.06

1.2

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.10

0.06

1.3

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

248

0.97

0.05

1.5

2.6

1.08

207

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

326

1751

0.99

0.04

1.2

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

102

0.94

0.04

1.3

1.4

27.7

24.0

0.15

(3035880) pH of Pleural fluid

438

1.02

0.04

1.3

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

101

1.05

0.03

1.2

1.9

ug/l

1.4

2.7

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

101

1.05

0.03

2.7

u/l

634.3

1313.1

0.41

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.06

0.03

1.1

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

107

1.04

0.02

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

119

640

0.99

0.02

1.5

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

357

0.98

0.02

2.6

3.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.06

0.01

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.06

0.01

1.1

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.96

0.00

1.6

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

385

1.01

0.00

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

147

0.98

0.00

1.3

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

230

1221

1.00

0.00

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

117

1.00

0.00

1.1

1.3

mmol/l

5.4

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.97

0.00

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

226

0.99

0.00

2.4

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

226

0.99

0.00

2.4

2.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

150

0.99

0.00

1.7

1.9

mmol/l

1.2

0.18

145

(3017509) Phencyclidine [Presence] in Urine

104

0.97

0.00

2.2

2.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.94

0.00

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.00

0.00

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.95

0.00

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.89

0.00

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.92

0.00

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.96

0.00

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.96

0.00

1.2

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

0.96

0.00

1.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_COXIBS – Coxibs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Coxibs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Coxibs (RX_COXIBS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints